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Abstract Sleep is an essential and phylogenetically conserved behavioral state, but it remains
unclear to what extent genes identified in invertebrates also regulate vertebrate sleep. RFamide-
related neuropeptides have been shown to promote invertebrate sleep, and here we report that
the vertebrate hypothalamic RFamide neuropeptide VF (NPVF) regulates sleep in the zebrafish, a
diurnal vertebrate. We found that NPVF signaling and npvf-expressing neurons are both necessary
and sufficient to promote sleep, that mature peptides derived from the NPVF preproprotein
promote sleep in a synergistic manner, and that stimulation of npvf-expressing neurons induces
neuronal activity levels consistent with normal sleep. These results identify NPVF signaling and
npvf-expressing neurons as a novel vertebrate sleep-promoting system and suggest that RFamide
neuropeptides participate in an ancient and central aspect of sleep control.
DOI: https://doi.org/10.7554/eLife.25727.001
Introduction
Sleep is an essential, phylogenetically conserved behavioral state whose regulation requires several
brain regions that engage multiple neurochemical systems (Allada and Siegel, 2008;
Cirelli, 2009). Historically, stereotactic lesion experiments have demonstrated a central role in sleep
regulation for the hypothalamus (Saper et al., 2010; Weber and Dan, 2016), a structure that is
anatomically and molecularly conserved between zebrafish and mammals (Biran et al., 2015;
Chiu and Prober, 2013; Liu et al., 2015; Shimogori et al., 2010). More recent genetic approaches
have corroborated a critical role for hypothalamic regulation of vertebrate sleep, due in part to pro-
duction of specific wake- and sleep-promoting neuropeptides (Richter et al., 2014). However, only
a small number of such neuropeptides have been identified, suggesting that additional neuropepti-
des remain to be discovered. Indeed, the hypothalamus produces many neuropeptides (van den
Pol, 2012), but potential roles in sleep for most of these neuropeptides, and the neurons that pro-
duce them, are largely unknown.
Sleep has primarily been studied using mammals, where electrophysiology can be used to define
sleep and wake states. However, progress has been challenging, due in part to the complexity of
mammalian brains, the significant cost and labor required to generate and test mutant and trans-
genic rodents, and the poor amenability of mammalian model systems for large-scale screens. To
overcome these limitations, several groups have established invertebrate sleep models by using
behavioral criteria to define sleep-like states (Allada and Siegel, 2008; Cirelli, 2009). First, sleep pri-
marily occurs during specific periods of the circadian cycle during which animals usually adopt an
inactive and specific posture. In mice, an inactive period of 40 seconds significantly correlates with
electroencephalographic indications of sleep (Pack et al., 2007). Second, animals exhibit an
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increased arousal threshold during sleep, thus distinguishing sleep from quiet wakefulness. However,
sleeping animals can still be aroused by strong stimuli, which distinguishes sleep from paralysis or
coma. Third, sleep is controlled by a homeostatic system, which can be demonstrated by an
increased need for sleep following sleep deprivation. Based on these criteria, rest in nematodes, flies
and zebrafish (Hendricks et al., 2000; Prober et al., 2006; Raizen et al., 2008; Shaw et al., 2000;
Van Buskirk and Sternberg, 2007; Yokogawa et al., 2007; Zhdanova et al., 2001) has been shown
to be a sleep-like state (for simplicity, hereafter referred to as sleep). These model organisms have
been used to perform genetic and genomic screens that have identified many genes that affect
sleep (Chiu et al., 2016; Cirelli et al., 2005; Koh et al., 2008; Nath et al., 2016; Shang et al.,
2013; Shi et al., 2014; Trojanowski et al., 2015), including several neuropeptides. However, hypo-
thalamic neuropeptides implicated in regulating vertebrate sleep, including hypocretin (Hcrt)
(Adamantidis et al., 2007; de Lecea et al., 1998; Lin et al., 1999) and melanin concentrating hor-
mone (MCH) (Konadhode et al., 2013; Tsunematsu et al., 2014; Verret et al., 2003; Willie et al.,
2008) lack clear invertebrate orthologs, suggesting that neuropeptidergic regulation of sleep may
have evolved independently in vertebrates and invertebrates. Thus, it remains to be determined
whether neuropeptides that regulate invertebrate sleep are functionally conserved in vertebrates.
Members of a neuropeptide family that contain a C-terminal Arg-Phe-NH2 motif, known as RFa-
mides, play key roles in promoting invertebrate sleep (He et al., 2013; Iannacone et al., 2017;
Lenz et al., 2015; Nagy et al., 2014; Nath et al., 2016; Nelson et al., 2014; Shang et al., 2013;
Turek et al., 2016). Vertebrates possess several RFamide family members (Elphick and Mirabeau,
2014), including the hypothalamic neuropeptide VF (NPVF). Mammalian NPVF (also known as RFRP
or GnIH) was first identified in a bioinformatic screen for human RFamide neuropeptides
(Hinuma et al., 2000). The human NPVF preproprotein produces three mature peptides, known as
RFamide-related peptide (RFRP) 1, RFRP2, and RFRP3 (Hinuma et al., 2000). In rodents, intracere-
broventricular infusion of synthetic RFRP1 or RFRP3 has been reported to affect hormone levels,
food intake, sexual behavior and nociception (Kim, 2016; Kriegsfeld et al., 2015; Liu et al., 2001;
Tsutsui et al., 2015; Ubuka et al., 2012). RFRP1 and RFRP3 can bind to NPFFR1 and NPFFR2 in
mammalian cell culture, but RFRP2 does not and its cognate receptor(s) remains unknown
(Hinuma et al., 2000; Liu et al., 2001). In the brain, NPVF is enriched within and around the dorso-
medial hypothalamus in rodents (Liu et al., 2001; Poling et al., 2012) and humans (Ubuka et al.,
2009), a region associated with sleep regulation (Saper et al., 2010). However, genetic gain- or
loss-of-function sleep studies of mammalian NPVF-derived neuropeptides or npvf-expressing neu-
rons (hereafter referred to as NPVF neurons) have not been reported.
Here we address the role of NPVF in regulating vertebrate sleep using the zebrafish, a vertebrate
that allows for rapid and cost-effective testing of genes for effects on behavior (Chiu et al., 2016).
The zebrafish has been shown to exhibit a diurnal pattern of sleep/wake states using the behavioral
criteria described above. Based on locomotor activity and arousal threshold assays, one or more
minutes of inactivity correspond to a sleep state in zebrafish larvae (Elbaz et al., 2012;
Prober et al., 2006). The zebrafish has genetic (Cirelli, 2009; Richter et al., 2014; Sehgal and
Mignot, 2011), pharmacological (MacRae and Peterson, 2015) and neuroanatomical (Kaslin and
Panula, 2001;McLean and Fetcho, 2004; Prober et al., 2006) similarities to mammalian sleep, sug-
gesting that findings in zebrafish will translate to mammals. Using genetics, pharmacology, chemo-
genetics and optogenetics, we show that NPVF signaling and NPVF neurons are both necessary and
sufficient to promote sleep, and that stimulation of NPVF neurons induces levels of neuronal activity
consistent with normal sleep. These results establish RFamide neuropeptides as evolutionarily con-
served sleep-promoting systems.
Results
Overexpression of NPVF promotes sleep in zebrafish larvae
Recent studies using Drosophila melanogaster (Drosophila) and Caenorhabditis elegans (C. elegans)
demonstrated that several RFamide peptides, as well as the neurons that produce them, are neces-
sary and sufficient to promote invertebrate sleep (He et al., 2013; Iannacone et al., 2017;
Lenz et al., 2015; Nath et al., 2016; Nelson et al., 2014; Shang et al., 2013; Trojanowski et al.,
2015; Turek et al., 2016). A library of peptides was previously used to screen for zebrafish sleep
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phenotypes, but the library did not include RFamide peptides (Chiu et al., 2016). We therefore set
out to test the hypothesis that RFamide peptides can also promote sleep in vertebrates. One C. ele-
gans sleep-promoting RFamide peptide, FLP-13, is sufficient to induce sleep (Nath et al., 2016;
Nelson et al., 2014) and is necessary for sleep in response to cellular stress (Nelson et al., 2014).
The vertebrate RFamide whose mature peptide sequences most closely resemble those of FLP-13 is
NPVF. The three mature peptides derived from NPVF (RFRP1-3) contain a conserved C-terminal
Figure 1. NPVF overexpression decreases locomotor activity and increases sleep. (A) Multiple sequence alignment of human (Hs), mouse (Mm), and
zebrafish (Dr) NPVF preproproteins. Colored boxes demarcate identified or predicted mature peptide sequences. Note that the mouse NPVF protein
lacks RFRP2. (B–I) NPVF overexpression decreased locomotor activity (B,D) and increased sleep (C,E) in transgenic animals compared to WT siblings
and to pre-HS. Yellow bar indicates heat shock. Pre- and Post-HS data is calculated for the day of HS. White and black bars under behavioral traces
indicate day (14 h) and night (10 h), respectively. NPVF overexpression decreased wake activity (F), decreased sleep latency (time to first sleep bout
following lights on in the morning Pre-HS, or following HS in post-HS measurement) (H) and increased sleep bout number (I), and also caused a trend
of increased sleep bout length (G). Mean ± SEM from one representative experiment (B,C), or three pooled experiments (D–I) are shown. n = number
of animals. ***p<0.0001 by Two-way ANOVA with Holm-Sidak test. See also Figure 1—figure supplements 1–3.
DOI: https://doi.org/10.7554/eLife.25727.002
The following figure supplements are available for figure 1:
Figure supplement 1. Overexpression of C. elegans FLP-13 decreases locomotor activity in zebrafish larvae.
DOI: https://doi.org/10.7554/eLife.25727.003
Figure supplement 2. NPVF overexpression in the evening promotes sleep the following night and day.
DOI: https://doi.org/10.7554/eLife.25727.004
Figure supplement 3. npvf expression levels do not vary in a circadian manner and NPVF overexpression-induced sleep does not require entrained
behavioral circadian rhythms.
DOI: https://doi.org/10.7554/eLife.25727.005
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LPXRF motif (where X = L or Q) (Figure 1A) that is critical for peptide function (Findeisen et al.,
2011). The nine peptides derived from FLP-13 contain a similar C-terminal PXIRF motif (where X = L
or F) (Figure 1—figure supplement 1A).
To determine whether NPVF overexpression affects sleep, we generated a stable transgenic
zebrafish line in which a heat shock-inducible promoter regulates expression of the zebrafish npvf
open reading frame. After heat shock-induced overexpression of NPVF, we found that these animals
were 71% less active, had 62% less wake activity (amount of activity while awake), and slept 350%
more during the day compared to their non-transgenic wild-type (WT) siblings (Figure 1B–1F) (activ-
ity, wake activity and sleep: p<0.0001, Two-way ANOVA, Holm-Sidak test). The increase in sleep
was primarily due to an increase in the number of sleep bouts (+331%, p<0.0001, Two-way ANOVA,
Holm-Sidak test), along with a modest increase in the length of sleep bouts (+21%) that did not
reach statistical significance (Figure 1G and I). NPVF overexpression also drove the transition from
wake-to-sleep by 2850% compared to WT siblings, with the average transgenic animal falling asleep
in 3.7 ± 0.4 min immediately following heat shock compared to 108.9 ± 16.0 min for WT siblings
(p<0.0001, Two-way ANOVA, Holm-Sidak test, Figure 1H).
Interestingly, induction of NPVF overexpression in the middle of the day did not affect sleep the
following night. A previous study suggested that the circadian system prevents premature sleep
onset in the evening, when homeostatic sleep drive is high (Cavanaugh et al., 2016). However,
when we induced NPVF overexpression at the end of the day, fifteen minutes before lights off, we
observed significantly decreased locomotor activity ( 36%) and increased sleep (+20%) during the
night, as well as the following day (Locomotor activity:  14%; Sleep: 124%) compared to WT siblings
(all: p<0.0001, Two-way ANOVA, Holm-Sidak test, Figure 1—figure supplement 2), although the
effect during the following day was smaller than that observed when NPVF overexpression was
induced in the middle of the day. These observations suggest that the absence of a phenotype at
night following heat shock during the middle of the day is due to declining levels of overexpressed
NPVF protein, rather than circadian regulation of NPVF function. This interpretation is supported by
our observation that the level of npvf mRNA, assayed using RT-qPCR and in situ hybridization (ISH),
does not vary in a circadian manner (p>0.05, One-way ANOVA, Figure 1—figure supplement 3A
and B).
To further test whether NPVF-induced sleep is regulated by circadian cues, we raised and tested
animals in either constant light (LL) or dark (DD) from birth, which prevents the establishment of cir-
cadian rhythms (Gandhi et al., 2015; Hurd and Cahill, 2002; Kaneko and Cahill, 2005). Following
heat-shock in LL, NPVF-overexpressing animals were 60% less active and slept 75% more than their
WT siblings (Figure 1—figure supplement 3C–G) (activity and sleep: p<0.0001, Two-way ANOVA,
Holm-Sidak test). To test whether light affects this phenotype, we raised and tested animals in DD,
and observed similar effects on overall activity and sleep as in LL (Figure 1—figure supplement 3J–
N). Interestingly, we observed differences in sleep architecture between LL and DD. In LL, the
increase in NPVF-induced sleep was due to a 200% increase in the number of sleep bouts compared
to WT siblings (p<0.0001; Two-way ANOVA, Holm-Sidak test) (Figure 1—figure supplement 3H
and I). In DD, increased sleep in NPVF-overexpressing animals was due to a 75% increase in sleep
bout length compared to WT siblings (p<0.0001, Two-way ANOVA, Holm-Sidak test), with no effect
on the number of sleep bouts (Figure 1—figure supplement 3O and P). Together, these results
suggest that NPVF-induced sleep does not require circadian rhythms or depend on lighting condi-
tions, although effects on sleep architecture are influenced by lighting conditions.
These results indicate that the ability of RFamide neuropeptides to promote sleep is conserved in
invertebrates (He et al., 2013; Iannacone et al., 2017; Lenz et al., 2015; Nath et al., 2016;
Nelson et al., 2014; Shang et al., 2013; Trojanowski et al., 2015; Turek et al., 2016) and verte-
brates. We next asked whether the C. elegans sleep-promoting RFamide FLP-13 is sufficient to
affect behavior in zebrafish. To answer this question, we generated transgenic zebrafish in which
expression of the C. elegans flp-13 open reading frame is regulated by a heat shock-inducible pro-
moter. We found that overexpression of FLP-13 decreased locomotor activity by 26% compared to
WT siblings (Figure 1—figure supplement 1B) (p<0.0001, Two-way ANOVA, Holm-Sidak test).
However, FLP-13 overexpression did not significantly affect sleep (Figure 1—figure supplement
1C). These results are consistent with the notion that RFamide peptides have an evolutionarily con-
served role in suppressing motor behaviors, even though the behavioral effect of overexpressing
FLP-13 in zebrafish is weaker than that of its potential zebrafish homolog NPVF.
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Mature peptides derived from NPVF synergistically promote sleep
In humans and zebrafish, npvf encodes for a preproprotein that contains three mature peptides
(RFRP1-3) (Ubuka and Tsutsui, 2014). To determine whether individual mature peptides are suffi-
cient to promote sleep, we generated transgenic zebrafish that contained heat-shock inducible
transgenes in which the amino acid sequence of one or more mature peptides was scrambled to
abolish its function (Figure 2). Heterozygous transgenic animals were mated to WT animals, and
their heterozygous transgenic and WT larval progeny were assayed for locomotor activity and sleep
phenotypes. Overexpression of a transgene in which all three peptides were scrambled had no
behavioral effect (Figure 2D–F and N), indicating that one or more peptides are required for NPVF
overexpression-induced sleep. Compared to their WT siblings, overexpression of transgenes con-
taining only RFRP1 or RFRP3 decreased activity by 18% or 14%, respectively (both: p<0.0001, One-
way ANOVA, Holm-Sidak test), but had no significant effect on sleep (Figure 2D, E, G, I, O and Q).
Overexpression of RFRP2 (present in the human but not rodent npvf ortholog) had a stronger effect,
decreasing locomotor activity by 56% and increasing sleep by 120% (activity and sleep: p<0.0001,
One-way ANOVA, Holm-Sidak test) (Figure 2D, E, H and P). Compared to their WT siblings, overex-
pression of transgenes containing any combination of two RFRP peptides induced significantly larger
activity and sleep phenotypes, similar to overexpression of WT NPVF, with >70% decreased locomo-
tor activity and >200% increased sleep (activity and sleep: p<0.0001, One-way ANOVA, Holm-Sidak
test) (Figure 2D, E, J–M and R–U).
To test whether the behavioral effects induced by overexpression of two or more RFRP peptides
is due to a dosage effect, we compared sleep in animals containing 0 (WT), 1 (heterozygous trans-
genic) or 2 (homozygous transgenic) copies of the hs:RFRP1, hs:RFRP3 or hs:RFRP1-3 transgenes.
Following heat-shock induced overexpression, we observed no difference in locomotor activity or
sleep amount between WT, Tg(hs:RFRP1)/+ and Tg(hs:RFRP1)/Tg(hs:RFRP1) animals (Figure 2—fig-
ure supplement 1A–D). Similarly, we observed no difference in amount of locomotor activity or
sleep between Tg(hs:RFRP3)/+ and Tg(hs:RFRP3)/Tg(hs:RFRP3) animals (Figure 2—figure supple-
ment 1F and H). We observed a small decrease in locomotor activity in Tg(hs:RFRP3)/Tg(hs:RFRP3)
compared to +/+ animals (Figure 2—figure supplement 1E and G), but the effect was much smaller
than that observed for Tg(hs:RFRP1,3)/+ compared to +/+ animals (Figure 2K and S). Finally, we
compared +/+, Tg(hs:RFRP1-3)/+, and Tg(hs:RFRP1-3/hs:RFRP1-3) animals and observed that
RFRP1-3 overexpression increased sleep and decreased locomotor activity to a similar extent in het-
erozygous and homozygous transgenic animals compared to +/+ siblings (Figure 2—figure supple-
ment 1I–L). Taken together, these results suggest that the larger phenotypes observed following
overexpression of 2 or more different RFRP peptides compared to single peptides is due to
the synergistic action of these peptides rather than a dosage effect.
To compare the effect of overexpressing different RFRP peptides on neuronal activity in the brain,
we performed ISH using a probe specific for c-fos, which can be used as a marker of neuronal activity
(Guzowski et al., 2005). One hour after heat shock, we observed robust induction of c-fos expres-
sion along the brain ventricular lining in transgenic animals that overexpressed WT npvf, whereas
their non-transgenic siblings lacked c-fos expression in this region (Figure 2—figure supplement
2A–C). In several vertebrates, including fish, hypothalamic RFamidergic neurons have been
described as cerebrospinal fluid (CSF)-contacting neurons (Castro et al., 2001), suggesting that acti-
vation of cells along the brain ventricle by RFRP peptides could drive behavioral state changes by
inducing signals in the CSF to promote sleep, as has been described for several sleep regulators
(Krueger et al., 2007). Consistent with the behavioral phenotypes induced by overexpression of dif-
ferent RFRP peptides, we observed robust ventricular c-fos expression in animals that overexpressed
any combination of two RFRP peptides (Figure 2—figure supplement 2J and data not shown) or
RFRP2 alone (Figure 2—figure supplement 2H), reduced c-fos expression in animals that overex-
pressed RFRP1 or RFRP3 (Figure 2—figure supplement 2G and I), and no c-fos expression in ani-
mals that overexpressed a transgene in which all three peptides were scrambled (Figure 2—figure
supplement 2F). Taken together with the behavioral data (Figure 2 and Figure 2—figure supple-
ment 1), these changes in c-fos expression suggest that NPVF overexpression-induced sleep results
from synergistic effects of RFRP peptides.
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Figure 2. Individual RFRP peptides act synergistically to promote sleep. (A) Schematic diagram of the NPVF preproprotein and its three RFRP peptides.
(B) Eight heat shock-inducible transgenes containing all possible combinations of one, two or three scrambled RFRP peptides tested. Colors
correspond to those used in panels (C–U). (C) Amino acid sequences of zebrafish Tg(hs:NPVF) transgenes containing single or multiple scrambled RFRP
peptides. RFRP peptide sequences are predicted based on conservation with peptides isolated in other species and on the location of glycine
Figure 2 continued on next page
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Loss of NPVF signaling results in reduced sleep
We next tested the hypothesis that NPVF signaling is required for normal sleep levels. Using
CRISPR/Cas9, we generated a zebrafish npvf mutant that contains a 7 bp deletion after the first
amino acid of RFRP2 (Figure 3—figure supplement 1A). This mutation results in a shift in the trans-
lational reading frame and produces a protein that contains RFRP1 but lacks RFRP2 and RFRP3. Con-
sistent with the NPVF overexpression phenotype, we found that npvf -/- animals were 27% more
active and slept 10% less than their npvf +/+ siblings at night (sleep: p<0.05; activity: p<0.005, One-
way ANOVA, Holm-Sidak Test) (Figure 3A–D). These effects were due to a 10% reduction in sleep
bout length and a 19% increase in wake activity in npvf -/- animals compared to their npvf +/+ sib-
blings (p<0.01 and p<0.005, respectively, One-way ANOVA, Holm-Sidak test) (Figure 3—figure
supplement 1B–E). npvf +/- animals exhibited an intermediate sleep phenotype that was not signifi-
cantly different from that of their npvf -/- siblings (night: p=0.3, One-way ANOVA, Holm-Sidak test)
(Figure 3C and D). This result suggests that NPVF signaling is required for normal sleep levels.
Because the behavioral phenotype of npvf -/- animals, which chronically lack NPVF signaling, is
relatively mild, we used pharmacology as an alternative approach to acutely inhibit NPVF signaling.
We tested two pharmacological inhibitors of NPFFR1 and NPFFR2, the GPCRs that bind RFRP1 and
RFRP3 in vitro (Hinuma et al., 2000; Liu et al., 2001). Treatment of WT animals with the dipeptide
antagonist RF9 (Simonin et al., 2006) resulted in more activity (day: 28%; night: 20%) and less sleep
(day:  47%; night:  24%) than animals treated with DMSO vehicle control during both the day and
night (p<0.0001, Student’s t-test) (Figure 3E–3H). Changes in sleep were associated with fewer and
shorter sleep bouts at night, but only to fewer sleep bouts during the day (Figure 3—figure supple-
ment 1G and H). RF9 also significantly increased wake activity during the day (21%) and night (7%),
and sleep latency after lights off at night (74%) compared to DMSO-treated controls (p<0.0001, Stu-
dent’s t-test) (Figure 3—figure supplement 1F and I). Similarly, treatment of WT animals with GJ-
14, an additional dipeptide antagonist of NPFFR1 and NPFFR2 (Kim et al., 2015), resulted in signifi-
cantly increased locomotor activity (day: 9%; night: 43%) and decreased sleep (day:  36%; night:
 24%) during the day and night (p<0.0001, Student’s t-test) (Figure 3I–3L). Although the effects of
GJ-14 were smaller than those of RF9, GJ-14 had similar effects on sleep architecture as RF9 (Fig-
ure 3—figure supplement 1K and L). These results suggest that NPVF signaling is required for both
the initiation and maintenance of normal levels of sleep during the day and night.
To confirm that RF9 and GJ-14 are acting by inhibiting NPFFR receptors, we tested whether
these antagonists block sleep induced by overexpression of RFRP1,3, the cognate ligands of these
receptors. In independent behavioral experiments, Tg(hs:RFRP1,3) animals and their WT siblings
were treated with either RF9, GJ-14, or DMSO vehicle control in clutch matched controls. RFRP1,3
overexpression induced sleep post-HS compared to pre-HS in DMSO vehicle treated animals (Fig-
ure 3—figure supplement 2A, B, E and F). In contrast, RFRP1,3 overexpression-induced sleep was
suppressed post-HS compared to pre-HS in animals treated with RF9 (Figure 3—figure supplement
2C and D) and completely blocked by GJ-14 treatment (Figure 3—figure supplement 2G and H).
These results are consistent with in vitro data showing that RFRP1 and RFRP3 bind NPFFR1 and
NPFFR2 (Hinuma et al., 2000; Liu et al., 2001). These data suggest that decreased sleep due to
treatment with these drugs can be attributed to inhibition of NPVF signaling.
Figure 2 continued
amidation signals and lysine or arginine endoproteolytic cleavage sites. The C-terminus of each predicted peptide contains a LPXRF motif, where X = L
or Q. Gray shading indicates scrambled sequences. Daytime activity (D) and sleep (E) of transgenic animals normalized to their WT siblings following
afternoon heat-shock-induced transgene overexpression are shown as mean ± SEM for two pooled experiments, with at least 64 animals per genotype.
Examples of activity and sleep data for each transgene are shown in (F–U). Yellow bars indicate heat shock. White and black bars under behavioral
traces indicate day (14 hr) and night, respectively. n = number of animals. n.s. = not significant, ***p<0.0001 by One-way ANOVA compared to
scrambled NPVF peptide control (black) using Dunnett’s multiple comparison test. See also Figure 2—figure supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.25727.006
The following figure supplements are available for figure 2:
Figure supplement 1. RFRP-induced sleep is not due to a dose-response of individual RFRP peptides.
DOI: https://doi.org/10.7554/eLife.25727.007
Figure supplement 2. c-fos expression correlates with overexpression of RFRP peptides that induce sleep.
DOI: https://doi.org/10.7554/eLife.25727.008
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Figure 3. Genetic and pharmacological inhibition of NPVF signaling increases locomotor activity and decreases
sleep. (A–D) npvf -/- animals are more active during the day and night (A,B), and sleep less at night (C,D)
compared to their npvf +/+ siblings. npvf +/- animals show an intermediate sleep phenotype that is not
significantly different than npvf -/- siblings. (E–L) Pharmacological inhibition of NPVF signaling by the NPFFR1/2
antagonists RF9 and GJ-14 increased locomotor activity (E,F,I,J) and decreased sleep (G,H,K,L) during the day and
night compared to DMSO control-treated siblings. Mean ± SEM from one representative experiment (A,C,E,G,L,
K), three pooled experiments (F,H,J,L), or six pooled experiments (B,D) are shown. White and black bars under
behavioral traces indicate day (14 h) and night (10 h), respectively. n = number of animals. *p<0.05; ***p<0.005 by
Figure 3 continued on next page
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NPVF signaling affects arousal threshold
Sleep is distinguished from quiet wakefulness by an increased arousal threshold, which we assayed
by delivering mechano-acoustic stimuli of variable intensities to zebrafish larvae while monitoring
their behavior (Gandhi et al., 2015). We monitored the fraction of animals that responded to the
stimulus at several intensities and used this data to construct dose-response curves. Based on these
curves, we calculated the tapping intensity at which the half-maximal response occurred (effective
tap power 50, ETP50). We observed that the ETP50 for NPVF-overexpressing larvae was 227% higher
than that of their WT siblings (Figure 4A) (p<0.0001 by extra sum-of-squares F test). Conversely the
ETP50 for RF9- or GJ-14-treated animals was 46% or 66% lower than that of their DMSO-treated sib-
lings, respectively (Figure 4B and C) (both: p<0.0001 by extra sum-of-squares F test). These results
demonstrate that NPVF overexpression increases arousal threshold, whereas inhibition of NPVF sig-
naling decreases arousal threshold.
Identification of a genomic element that drives gene expression in
NPVF neurons
In mammalian brains, npvf is highly enriched in the dorsomedial hypothalamus (Hinuma et al., 2000;
Liu et al., 2001; Ubuka et al., 2009). Similarly, using ISH we found that npvf is exclusively expressed
in the zebrafish dorsomedial hypothalamus at 5 days post-fertilization (dpf) (Figure 5A–C), similar to
previous observations (Madelaine et al., 2017; Yelin-Bekerman et al., 2015). However, zebrafish
larvae only have ~15 NPVF neurons per brain hemisphere, over an order of magnitude fewer than
Figure 3 continued
One-way ANOVA with Holm-Sidak test (B,D) and Student’s t-test (F,H,J,L). See also Figure 3—figure
supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.25727.009
The following figure supplements are available for figure 3:
Figure supplement 1. Genetic and pharmacological inhibition of NPVF signaling alters sleep/wake architecture.
DOI: https://doi.org/10.7554/eLife.25727.010
Figure supplement 2. Pharmacological inhibition of NPVF signaling suppresses RFRP-overexpression induced
sleep.
DOI: https://doi.org/10.7554/eLife.25727.011
Figure 4. NPVF signaling affects arousal threshold. Representative stimulus response curves generated using a mechano-acoustic stimulus in Tg(hs:
NPVF) animals and their WT siblings following heat shock (A), in RF9 and DMSO vehicle treated WT larvae (B), and in GJ-14 and DMSO vehicle treated
WT larvae (C). Each data point indicates mean ± SEM. Dashed lines mark the ETP50 value for each genotype or drug treatment. (A) Tg(hs:NPVF) animals
had an ETP50 value of 20.3 vs. 6.2 for WT siblings (227% increase, F(1,834)=16.05, p<0.0001 by extra sum-of-squares F test). (B) RF9-treated animals had
an ETP50 of 2.5 vs. 4.7 for DMSO-treated siblings (46% decrease, F(1,834)=24.19, p<0.0001 by extra sum-of-squares F test). (C) GJ14-treated animals had
an ETP50 of 2.8 vs. 8.2 for DMSO-treated siblings (65% decrease, F(1,834)=49.47, p<0.0001 by extra sum-of-squares F test). n = number of animals.
DOI: https://doi.org/10.7554/eLife.25727.012
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Figure 5. Optogenetic stimulation of NPVF neurons promotes sleep. (A) ISH of NPVF neurons (arrowhead) in a 5-dpf brain. Ventral (A) and side (A’)
views are shown. a, anterior; p, posterior; d, dorsal. (B) Live image of a 5-dpf Tg(npvf:EGFP) zebrafish with brightfield and EGFP overlay. White box
demarcates region shown in subsequent images. (C) EGFP and npvf coexpression shown using EGFP immunohistochemistry (IHC) and npvf FISH in a
43.4 mm thick image stack. (D) npvf and vglut2a coexpression shown using FISH in a 2.7 mm thick image stack. (E) mCitrine and npvf coexpression in a
Tg(npvf:ReaChR-mCitrine) zebrafish shown using EGFP IHC and npvf FISH in a 2.7 mm thick image stack. (F–H) Tg(npvf:ReaChR-mCitrine) and WT
siblings were exposed to the same blue light stimulus used in (I–L). (G,H) 75.1 ± 4.1% of NPVF neurons expressed c-fos in Tg(npvf:ReaChR-mCitrine)
animals (***p<0.0001; One-way ANOVA with Dunnett’s test to sham), in contrast to similarly stimulated WT siblings (~1%, n.s., not significant) (F,H), or
to sham-treated transgenic animals (~1%). (I–L) Optogenetic stimulation of NPVF neurons decreased locomotor activity and increased sleep in
transgenic animals compared to WT siblings. Data are from one representative experiment (I,K), or three pooled experiments (J,L). Activity and sleep of
transgenic animals are normalized to WT and represented as mean ± SEM (J,L). n = number of animals. ***p<0.0001 by Student’s t-test. Scale: 50 mm
(A,B), 20 mm (C,D), 10 mm (G). See also Table 1 and Figure 5—figure supplements 1,2.
DOI: https://doi.org/10.7554/eLife.25727.013
The following figure supplements are available for figure 5:
Figure supplement 1. NPVF neuronal projections.
DOI: https://doi.org/10.7554/eLife.25727.014
Figure supplement 2. Chemogenetic stimulation of NPVF neurons promotes sleep.
DOI: https://doi.org/10.7554/eLife.25727.015
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the number of NPVF neurons in mice (Poling et al., 2012). Using fluorescent in situ hybridization
(FISH), we observed that npvf-expressing neurons also express the glutamatergic markers vglut2a
(Figure 5D, 95 ± 3%, n = 4) and vglut2b (83 ± 3%, n = 6), and do not express the GABAergic marker
gad67 (data not shown, n = 3), suggesting that this neuronal population is excitatory in nature. We
further identified a 4 kb genomic region directly 5’ to the npvf open reading frame that is sufficient
to drive expression of enhanced green fluorescent protein (EGFP) specifically in npvf-expressing neu-
rons, with 98 ± 1% (n = 12) of EGFP positive cells expressing npvf mRNA, and 97 ± 1% (n = 12) of
npvf-positive cells expressing EGFP (Figure 5B and C, Table 1). This neuronal population sends
dense projections within the hypothalamus and to the raphe nuclei of the hindbrain
(Madelaine et al., 2017), and sparse projections to the forebrain, tectum, and spinal cord (Fig-
ure 5—figure supplement 1), suggesting that it may regulate neurons in these regions
(Madelaine et al., 2017).
Optogenetic stimulation of NPVF neurons promotes sleep
To test the hypothesis that NPVF neurons are sufficient to promote sleep, we generated transgenic
animals in which these neurons express the channelrhodopsin variant ReaChR (Lin et al., 2013) fused
to mCitrine (Figure 5E and Table 1). To determine whether this transgene can stimulate NPVF neu-
rons, we used a non-invasive, large-scale assay (Singh et al., 2015) in which freely-moving 5 dpf ani-
mals were exposed to blue light (470 nm at ~400 mW) for 30 min, and then performed double FISH
using probes specific for npvf and c-fos. We observed that 75% of npvf-expressing neurons were c-
fos positive in Tg(npvf:ReaChR-mCitrine) animals compared to ~1% in identically treated WT siblings
or in transgenic animals not exposed to blue light (sham; Figure 5F–H).
We next tested the behavioral effect of stimulating NPVF neurons using the same behavioral
assay. Tg(npvf:ReaChR-mCitrine) animals and their WT siblings exhibited similar baseline locomotor
activity levels. Upon blue light exposure, both transgenic and WT siblings responded with an
approximately 30 s burst of activity that we exclude from analysis, followed by a return to near base-
line activity levels, and a gradual increase in activity that plateaus after ~15 min (Figure 5I). During
blue light stimulation, locomotor activity was 27% lower (Figure 5I and J) and sleep was 55% higher
(Figure 5K and L) for Tg(npvf:ReaChR-mCitrine) animals compared to their WT siblings (activity and
sleep: p<0.0001, Student’s t-test). Thus, stimulation of NPVF neurons suppresses locomotor activity
and promotes sleep compared to non-transgenic controls, consistent with the NPVF overexpression
phenotype.
Table 1. Specificity of transgenic lines used in this study.
Specificity of transgenic lines was confirmed by FISH and/or IHC on dissected whole mount 5-dpf zebrafish brains. Each brain hemi-
sphere contains ~15 NPVF neurons. All neurons were counted in each hemisphere and percentage of co-expression is displayed as
mean ± SEM.
Transgenic line
Sample size
(brain
hemispheres)
Fluorescent-neurons
co-expressing npvf
npvf neurons co-expressing fluorescent-tagged
transgene
Tg(npvf:EGFP) 12 98.2 ± 1.0% 97.2 ± 1.1%
Tg(npvf:ReaChR-mCitrine) 12 97.1 ± 1.4% 94.1 ± 2.3%
Tg(npvf:mTagYFP-T2A-eNTR) 6 96.9 ± 2.3% 97.7 ± 1. 6%
Transgenic Line Sample size
(brain
hemispheres)
Red fluorescent neurons co-
expressing EGFP
EGFP-expressing NPVF neurons co-expressing
red fluorescence
Tg(npvf:KalTA4);
Tg(UAS:nfsb-mCherry);
Tg(npvf:EGFP)
16 100 ± 0.0% 100 ± 0.0%
Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-T);
Tg(npvf:EGFP)
4 88.8 ± 4.5% 92.3 ± 4.4%
DOI: https://doi.org/10.7554/eLife.25727.016
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Chemogenetic stimulation of NPVF neurons promotes sleep
As an alternative method to stimulate NPVF neurons that does not require a light stimulus, we used
an approach in which neurons expressing the rat TRPV1 channel are activated following addition of
its small molecule agonist capsaicin (Csn) to the water (Chen et al., 2016c). We generated Tg(npvf:
KalTA4) transgenic animals, in which NPVF neurons express an optimized form of the transcriptional
activator Gal4 (Distel et al., 2009), and Tg(UAS:TRPV1-TagRFP-T) transgenic animals, in which
TRPV1 expression is induced in KalTA4-expressing cells (Figure 5—figure supplement 1A, Table 1)
(Chen et al., 2016c). Following treatment with 2 mM Csn, Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-
T); Tg(npvf:EGFP) animals displayed higher levels of c-fos expression in NPVF neurons compared to
identically treated Tg(npvf:KalTA4); Tg(npvf:EGFP) siblings (Figure 5—figure supplement 1F G),
consistent with previous results demonstrating that Csn stimulates TRPV1-expressing neurons in vivo
(Chen et al., 2016c). Because higher concentrations of Csn (10 mM) can result in apoptosis
(Chen et al., 2016c), we compared the number of NPVF neurons in Tg(npvf:KalTA4); Tg(UAS:
TRPV1-TagRFP-T) animals to their Tg(npvf:KalTA4) siblings after treatment with 2 mM Csn. We
observed the same number of NPVF neurons for both genotypes, indicating that 2 mM Csn did not
result in the loss of TRPV1-expressing NPVF neurons (Figure 5—figure supplement 1L M).
We next tested the behavioral effect of stimulating TRPV1-expressing NPVF neurons. Tg(npvf:
KalTA4); Tg(UAS:TRPV1-TagRFP-T) and Tg(npvf:KalTA4) siblings treated with DMSO vehicle control
displayed no differences in locomotor activity or sleep (Figure 5—figure supplement 1B–E). In con-
trast, upon treatment with 2 mM Csn, Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-T) animals exhibited
20% more sleep and 13% less locomotor activity at night compared to Tg(npvf:KalTA4) siblings
(both p<0.001; Student’s t-test) (Figure 5—figure supplement 1H–K). While the behavioral pheno-
type induced using optogenetic stimulation of NPVF neurons was larger than that using TRPV1,
optogenetic stimulation induced more robust c-fos expression than TRPV1-dependent stimulation
(Figure 5G and Figure 5—figure supplement 2F), suggesting that more robust stimulation of NPVF
neurons was achieved using optogenetics. The different level of stimulation might result from differ-
ent transgene expression levels, acute stimulation with ReaChR versus prolonged stimulation with
TRPV1, or different effects of ReaChR and TRPV1 on neuronal physiology. Taken together, these
data show that chemogenetic stimulation of NPVF neurons promotes sleep, consistent with both the
NPVF optogenetic and overexpression data.
Chemogenetic ablation of NPVF neurons promotes wakefulness
To determine whether NPVF neurons are required for normal sleep levels, we generated Tg(npvf:
mTagYFP-T2A-eNTR) transgenic animals, in which NPVF neurons express membrane targeted
TagYFP and enhanced nitroreductase (eNTR) (Mathias et al., 2014; Tabor et al., 2014), which con-
verts the inert pro-drug metronidazole (MTZ) into a DNA cross-linking agent that induces cell-auton-
omous death (Figure 6A and Table 1). MTZ treatment of Tg(npvf:mTagYFP-T2A-eNTR) animals
resulted in nearly complete loss of NPVF neurons (Figure 6B and C). During both the day and night,
MTZ-treated transgenic animals were more active (+29% and +44%, respectively, both: p<0.005,
Student’s t-test) and slept less ( 49% and  10%, respectively, both: p<0.005, Student’s t-test) than
their MTZ-treated non-transgenic siblings (Figure 6D–6G). NPVF neuron-ablated animals exhibited
fewer sleep bouts (day:  43%; night:  9%, both: p<0.0001, Student’s t-test), increased wake activity
(day: +22%; night: +20%, both: p<0.0001, Student’s t-test), and increased sleep latency at night
(+25%, p<0.005, Student’s t-test) compared to non-transgenic sibling controls (Figure 6—figure
supplement 1A–D). These results indicate that NPVF neurons are necessary for both the initiation
and maintenance of normal sleep levels during the day and night, consistent with the phenotype
resulting from pharmacological inhibition of NPVF signaling (Figure 3 and Figure 3—figure supple-
ment 1F–I).
NPVF neuronal stimulation results in neuronal activity levels similar to
those normally observed at night
As an independent demonstration that NPVF neurons promote sleep, we developed an intravital
imaging assay of neuronal activity in the brain during normal sleep/wake states and in response to
stimulation of NPVF neurons. Two-photon selective plane illumination microscopy (2P-SPIM)
(Truong et al., 2011) was used to image neuronal activity in Tg(elavl3:H2B-GCaMP6s) animals, which
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express the genetically encoded calcium indicator GCaMP6s in most neurons (Vladimirov et al.,
2014). 2P-SPIM combines the high-speed and low photodamage of light sheet microscopy with the
high penetration depth and invisibility of 2P excitation light, which avoids visible light-induced per-
turbation of sleep. We entrained the animals in 13:11 h light:dark conditions until 5 dpf, and then
imaged GCaMP6s fluorescence in constant dark for over 36 h (at 1 Hz for 2 min every 15 min);
GCaMP6s fluorescence was measured in a region of the tectum due to its accessibility and suitability
for long-term imaging (Figure 7A, rectangle). To measure arousal, during each 2 min imaging trial
Figure 6. Chemogenetic ablation of NPVF neurons promotes wakefulness. (A) mTagYFP and npvf coexpression in
a 5-dpf Tg(npvf:mTagYFP-T2A-eNTR) zebrafish shown using YFP IHC and npvf FISH. (B–G) Tg(npvf:mTagYFP-T2A-
eNTR) and WT siblings were treated with 5 mM MTZ for 60 h. Behavior was monitored from 6 to 8 dpf. (B) npvf
ISH in 7-dpf Tg(npvf:mTagYFP-T2A-eNTR) zebrafish treated with DMSO or MTZ. Scale: 10 mm. NPVF neuronal loss
is quantified as mean ± SEM in (C). (D–G) Transgenic animals treated with MTZ were more active (D,E) and slept
less (F,G) than their identically treated WT siblings. Mean ± SEM for one representative experiment (D,F), or three
pooled experiments (E,G) are shown. White and black bars under behavioral traces indicate day (14 h) and night
(10 h), respectively. n = number of animals. ***p<0.005 by Two-way ANOVA with Holm-Sidak test (C) or Student’s
t-test (E,G). See also Table 1 and Figure 6—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.25727.017
The following figure supplement is available for figure 6:
Figure supplement 1. Chemogenetic ablation of NPVF neurons alters sleep/wake architecture.
DOI: https://doi.org/10.7554/eLife.25727.018
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Figure 7. NPVF neuronal activation induces tectal neuronal activity levels similar to normal sleep. (A) Representative 2P-SPIM image of a 6 dpf Tg
(elavl3:H2B-GCaMP6s) animal, ~70 mm from the dorsal surface. The white box indicates the region of the optic tectum analyzed in subsequent panels.
The white oval indicates the location of NPVF neurons. The inset shows a GCaMP6s image superimposed on a brightfield image. Scale: 50 mm. (B)
Neural activity, recorded as GCaMP6s fluorescence, of a representative animal during >36 h of imaging in DD. Imaging sessions were performed for 2
min at 1 Hz every 15 min. No light perturbation was applied during the first 31 s of each trial to record intrinsic brain activity. To assess arousal, a red
light was turned on at t = 32 s, gradually increased in intensity until t = 93 s, then turned off. We observed increased neural activity at light onset and
offset, with habituation in between. Signal is calculated as DF = F – F0 where F0 = lowest signal measured during the recording period. (C) Normalized
neural activity, plotted as function of time, smoothed over a 5-trial sliding window, and averaged over 5–25, 32–37, and 93–98 s time windows,
representing intrinsic, On-flash evoked response and Off-flash evoked response, respectively. Signal is normalized by FN = average intrinsic activity
during subjective day. (D) Correlation of evoked activity to intrinsic activity. (E,F) During subjective day, animals were imaged for 15 trials, each
consisting of 2 min of imaging at 1 Hz every 5 min. Conditions were identical to those used in (B). Representative neural activity recorded for individual
ReaChR- and ReaChR+ animals are shown. Optogenetic stimulation began after trial 5. Signal for each animal is calculated with baseline F0 = averaged
signal over the first five trials, then normalized by FN = peak of signal after red light is turned on, for the same animal. (G) Mean ± SEM of the
normalized neural activity for four Tg(elavl3:H2B-GCaMP6s); Tg(npvf:ReaChR-mCitrine) larvae (red) and three Tg(elavl3:H2B-GCaMP6s) siblings (blue).
(H) Mean ± SEM steady-state normalized neural activity after optogenetic activation, averaged over trials 10–15, shows 68% lower activity for ReaChR
+ animals than their ReaChR- siblings (p<0.001, two-sample t-test). See also Figure 7—figure supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.25727.019
The following figure supplements are available for figure 7:
Figure supplement 1. Effect of optogenetic stimulation of NPVF neurons on GCaMP6s fluorescence in the tectum of individual animals.
DOI: https://doi.org/10.7554/eLife.25727.020
Figure 7 continued on next page
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we applied an ambient red light of increasing intensity (on: t = 32 s; off: t = 93 s) (Figure 7B). Thus,
during each trial we imaged intrinsic activity (t = 0–31 s), as well as responses evoked by lights on
(t = 32 s) and lights off (t = 93 s). Both intrinsic and evoked activity followed the subjective day/night
cycle, with higher levels during subjective day (Figure 7B and C), and correlated magnitudes of
intrinsic and evoked responses (Figure 7D). This pattern of intrinsic activity is consistent with sleep/
wake oscillations. The decreased responsiveness to a stimulus during subjective night is consistent
with the increased arousal threshold that occurs during sleep, although it could also result from pro-
cesses regulated by the circadian clock (Emran et al., 2010). Thus, this assay allows long-term moni-
toring of neuronal activity in the brain during what appear to be normal day/night patterns of
neuronal activity and arousal levels.
To test whether sleep induced by activating NPVF neurons produces similar effects on neuronal
activity, we stimulated these neurons using ReaChR with focused red light while imaging GCaMP6s
fluorescence in a region of the tectum during subjective day. As expected for a visual response to
red light, fluorescence in the tectum of ReaChR-negative animals increased during the period of light
exposure (Figure 7E and G and Figure 7—figure supplement 1A). In contrast, after a transient
response to the focused red light, Tg(npvf:ReaChR-mCitrine) animals displayed a suppression of neu-
ronal activity to levels approaching those normally observed at night (Figure 7F–H and Figure 7—
figure supplement 1B). Suppression of tectal neuronal activity in the absence of visual stimuli during
subjective night, and in response to NPVF neuron stimulation, is surprising because vertebrate sen-
sory systems are thought to be activated similarly during sleep and wake states, with the thalamus
limiting responses to these stimuli during sleep (Coulon et al., 2012). Our data suggest that sleep-
promoting mechanisms may act upstream of the thalamus to inhibit brain regions that receive direct
input from sensory systems.
Chemogenetic stimulation of NPVF neurons suppresses neuronal
activity throughout the brain
As an alternative approach to stimulate NPVF neurons while monitoring neuronal activity in the brain
using 2P-SPIM, we compared GCaMP6s fluorescence in Tg(elavl3:H2B-GCaMP6s) animals that
expressed TRPV1 in NPVF neurons (Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-T)) to siblings that did
not (Tg(UAS:TRPV1-TagRFP-T)) during exposure to 2 mM Csn in 13:11 h light:dark conditions. To
analyze neuronal responses in a more comprehensive manner, we used principal component and
independent component analysis (PCA/ICA) to automatically segment 500–800 spontaneously active
neurons throughout a single optical section of the brain (Figure 7—figure supplement 2A and B).
Using this approach, we observed lower average levels of neuronal activity at night compared to the
day for Tg(UAS:TRPV1-TagRFP-T) control animals (7% decrease, p=0.023, one-sample t-test) (Fig-
ure 7—figure supplement 2C and E–G), similar to the results described above in the optic tectum
(Figure 7B and C). Stimulation of NPVF neurons in Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-T) ani-
mals had no significant effect on neuronal activity during the day compared to Tg(UAS:TRPV1-
TagRFP-T) sibling controls (p=0.68, two-sample t-test) (Figure 7—figure supplement 2F). However,
stimulation of NPVF neurons in Tg(npvf:KalTA4); Tg(UAS:TRPV1-TagRFP-T) animals dramatically sup-
pressed neuronal activity at night compared to the day (25% decrease, p=0.023, one-sample t-test)
(Figure 7—figure supplement 2D–G), and compared to Tg(UAS:TRPV1-TagRFP-T) siblings at night
(~3 fold difference, p=0.028, two-sample t-test) (Figure 7—figure supplement 2G). This result indi-
cates that stimulation of NPVF neurons using TRPV1 suppresses neuronal activity in the brain at
night, consistent with the increased sleep at night observed upon stimulation of NPVF neurons using
TRPV1 (Figure 5—figure supplement 2), and with our results using optogenetic stimulation of
NPVF neurons (Figure 5). We conclude that stimulation of NPVF neurons is sufficient to both
increase sleep and decrease neuronal activity in the brain.
Figure 7 continued
Figure supplement 2. Chemogenetic stimulation of NPVF neurons decreases neuronal activity at night.
DOI: https://doi.org/10.7554/eLife.25727.021
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Discussion
Identifying genes that regulate vertebrate sleep has been hampered, in part, by the difficulty of per-
forming genetic screens for behavioral phenotypes in rodent animal models. In contrast, genetic and
genomic screens using invertebrate models, such as flies and nematodes, have identified many
genes that regulate sleep (Cirelli et al., 2005; Iannacone et al., 2017; Koh et al., 2008; Nath et al.,
2016; Shang et al., 2013; Shi et al., 2014). For example, in Drosophila, loss of function of the RFa-
mide neuropeptide sNPF reduces sleep, whereas stimulation of sNPF-expressing neurons promotes
sleep (Shang et al., 2013). Similarly, in C. elegans, overexpression of several members of the FLP
family of RFamide neuropeptides promotes sleep (Nath et al., 2016; Nelson et al., 2014;
Trojanowski et al., 2015), while loss of function analysis revealed a requirement for select FLP neu-
ropeptides in regulating sleep duration (Chen et al., 2016b; Iannacone et al., 2017; Nath et al.,
2016; Nelson et al., 2014; Turek et al., 2016) or homeostasis (Nagy et al., 2014). Based on these
data, we reasoned that testing candidate vertebrate orthologs of invertebrate sleep regulators may
be a fruitful strategy to identify neuropeptides that regulate vertebrate sleep. Here we used this
approach to identify a vertebrate RFamide neuropeptide sleep-promoting system.
We found that signaling by neuropeptides derived from the vertebrate NPVF preproprotein, as
well as NPVF neurons, are both necessary and sufficient to promote sleep in zebrafish larvae. Similar
to C. elegans FLP-13 (Nath et al., 2016), we found that robust NPVF overexpression-induced sleep
requires the synergistic interaction of two or more RFRP peptides derived from the NPVF prepropro-
tein. While invertebrate RFamide neuropeptides share some amino acid similarity with vertebrate
RFRP peptides, it was unclear to what extent invertebrate neuropeptidergic sleep mechanisms are
conserved in vertebrates. Indeed, the conserved role of RFamide neuropeptides in promoting sleep
is surprising considering that previously described neuropeptidergic regulators of vertebrate sleep,
such as Hcrt (Chemelli et al., 1999; Lin et al., 1999) and MCH (Willie et al., 2008), lack clear inver-
tebrate orthologs. We recently showed that another vertebrate RFamide peptide, QRFP, promotes
sleep in zebrafish (Chen et al., 2016a), but its effects are much weaker than those of NPVF in zebra-
fish, and of FLP-13 in C. elegans (Nath et al., 2016; Nelson et al., 2014). Consistent with these
observations, the amino acid sequence of the C-terminus of the zebrafish QRFP peptide (GGFGFRF)
is less similar than those of the zebrafish RFRP peptides (LP[L/Q]RF) to the C. elegans FLP-13 pepti-
des (P[L/F]IRF). Thus, to our knowledge, this study provides the first example of a neuropeptide fam-
ily that has a strong role in regulating sleep in both vertebrates and invertebrates, suggesting that it
participates in an ancient and central aspect of sleep control.
Consistent with an important role for NPVF in regulating sleep is its prominent expression in the
hypothalamus, an ancient brain structure that is anatomically and molecularly conserved in mammals
and zebrafish (Biran et al., 2015; Liu et al., 2015; Shimogori et al., 2010). Classical lesion studies
found that the hypothalamus plays a critical role in promoting both sleep and wakefulness
(Saper et al., 2010; Weber and Dan, 2016). More recently, specific hypothalamic wake- and sleep-
promoting neuronal populations have been identified (Adamantidis et al., 2007; Chung et al.,
2017; Konadhode et al., 2013; Singh et al., 2015; Tsunematsu et al., 2014; Verret et al., 2003;
Willie et al., 2008). Some hypothalamic neurons are also proposed to regulate a switch between
sleep and wake states that are driven by neurons in the hypothalamus and brainstem, and affect neu-
rons in the forebrain (Saper et al., 2010). We found that stimulation or ablation of zebrafish NPVF
neurons resulted in increased sleep or wake, respectively, demonstrating that these neurons partici-
pate in hypothalamic regulation of sleep. We also observed that zebrafish NPVF neurons send dense
projections to hypothalamic and brainstem regions, as well as sparse projections to the forebrain.
Therefore, the anatomical location and projection pattern of NPVF neurons, combined with our
behavioral results, suggests that these neurons may act to integrate cues relevant to sleep and affect
hypothalamic, hindbrain and forebrain neurons that regulate sleep/wake states.
Studies in invertebrate organisms suggest that RFamide-expressing neurons may have arisen
from cells with dual sensory-neurosecretory properties that were the starting point for the evolution
of neurosecretory brain centers in Bilateria (Plickert and Schneider, 2004; Tessmar-Raible et al.,
2007). In C. elegans, the neurosecretory ALA neuron produces several sleep-promoting RFamide
neuropeptides including FLP-13 (Nath et al., 2016; Nelson et al., 2014), and is required for sleep
that is induced by cellular stressors, including noxious temperature, hypertonicity and tissue damage
(Hill et al., 2014; Nath et al., 2016). It remains unclear whether cellular stress induces sleep in
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vertebrates, but the increased sleep in observed in mammals during illness and following cellular
injury might be regulated by mechanisms analogous to those that promote cellular stress-induced
sleep in C. elegans (Davis and Raizen, 2017). We speculate that NPVF neurons may have a sensory
function to detect physiological changes such as cellular stress, integrate this information, and pro-
mote a behavioral state change from wake to sleep. Indeed, NPVF neurons project widely in the
hypothalamus and hindbrain (Figure 5—figure supplement 1) suggesting they receive input from
and influence large regions of the brain. These include the optic tectum (Figure 5—figure supple-
ment 1 and Figure 7), which processes light cues from the retina that may influence sleep, and brain
ventricular cells (Figure 2—figure supplement 2), which secrete factors into the cerebrospinal fluid
that can promote sleep (Krueger et al., 2007). This possibility can be addressed by identifying both
upstream and downstream mechanisms involved in NPVF-regulated sleep in the vertebrate brain,
and can also be informed by examining potentially homologous neurons in simpler species.
Most genes implicated in regulating sleep also affect other physiological and behavioral pro-
cesses. For example, Hcrt not only promotes arousal, but also regulates feeding, energy homeosta-
sis, reward seeking and addiction (Li et al., 2016). Previous studies of RFRP peptides in birds and
rodents have demonstrated roles in regulating reproductive behaviors and nociception (Kim, 2016;
Kriegsfeld et al., 2015; Tsutsui et al., 2010; Tsutsui et al., 2012; Tsutsui et al., 2015;
Ubuka et al., 2014), and a study in zebrafish implicated NPVF neurons in nociception
(Madelaine et al., 2017), but a role in sleep has not been reported. The rodent and avian studies
mostly used infusion of single, in vitro synthesized RFRP peptides that, in addition to potentially lack-
ing post-translational modifications that may be necessary for normal function, do not take into con-
sideration the combinatorial action of RFRP peptides to promote sleep. We found that genetic
overexpression of at least two distinct RFRP peptides is required to induce robust sleep in zebrafish.
Thus, similar to nematode FLP peptides (Nath et al., 2016), distinct RFRP peptides may work
together to control vertebrate sleep by inhibiting select behaviors associated with arousal, such as
reproduction (Tsutsui et al., 2015; Ubuka et al., 2014) and feeding (Ubuka et al., 2016). Consistent
with our findings, knockdown of npvf expression in Japanese quail (Ubuka et al., 2014) and the
white-crowned sparrow (Ubuka et al., 2014) increases locomotor activity. However, genetic gain- or
loss-of-function analyses have not been reported for npvf or its receptors in any other species, and a
function for NPVF neurons in regulating sleep had not previously been described.
Several aspects of the NPVF system make it a particularly interesting sleep regulator. First, zebra-
fish NPVF neurons are glutamatergic, and thus excitatory, in contrast to most previously described
sleep-promoting neurons, which are GABAergic, and thus inhibitory (Richter et al., 2014;
Saper et al., 2005). For example, the C. elegans sleep promoting neuron ALA, which produces FLP-
13, was recently shown to be GABAergic (Gendrel et al., 2016), suggesting a difference in how neu-
rons that produce FLP-13 in C. elegans and NPVF in zebrafish interact with the sleep neuronal cir-
cuitry. However, the excitatory nature of NPVF neurons in zebrafish is consistent with observations in
mammals, as RNA sequencing found that npvf-expressing neurons are glutamatergic in mice
(Chen et al., 2017), and NPVF neurons do not co-express the vesicular GABA transporter in mice
(Rizwan et al., 2014). Thus, NPVF neurons may regulate sleep via a neural circuit mechanism that is
distinct from previously described sleep-promoting neurons.
Second, the zebrafish and human NPVF orthologs contain three RFRP peptides (Ubuka and Tsut-
sui, 2014) in contrast to rodent and avian species, which lack RFRP2 (Hinuma et al., 2000; Liu et al.,
2001). The zebrafish may thus be a more appropriate model than rodents and birds for some
aspects of human NPVF function. The conservation of RFRP2 between zebrafish and humans is par-
ticularly important, because while we observed that overexpression of at least two RFRP peptides is
required to induce robust sleep, overexpression of RFRP2 alone was sufficient to significantly
increase sleep. These observations suggest that RFRP2 has stronger sleep-promoting effects than
RFRP1 or RFRP3. Consistent with these results, we found that overexpression of WT NPVF, any com-
bination of two distinct RFRP peptides or RFRP2 alone resulted in robust c-fos expression along the
brain ventricular lining from the hypothalamus to the hindbrain. This ventricular expression pattern is
reminiscent of the pattern of phosphorylated ERK that is associated with EGFR-induced rest in
rodents (Gilbert and Davis, 2009) and Drosophila (Foltenyi et al., 2007), and is consistent with the
link between EGFR and RFamide signaling in promoting sleep in C. elegans (Nath et al., 2016;
Nelson et al., 2014) and Drosophila (Lenz et al., 2015). Among the cells that line the brain ventri-
cle, subependymal neurons secrete into and detect the composition of the CSF (Vı´gh et al., 2004).
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These CSF-contacting cells are immunoreactive for neuropeptides found in the CSF, including RFa-
mide neuropeptides (Chiba et al., 1991). In humans, several RFamide peptides, including RFRP3,
are present in CSF (Burlet-Schiltz et al., 2002). Taken together with the c-fos expression data, these
observations suggest that RFRP peptides may promote sleep by inducing the release of factors into
the CSF. This hypothesis is consistent with classical studies that showed the CSF contains sleep-
inducing factors (Krueger et al., 2007). We note that RFRP2 peptide has yet to be detected in vivo,
possibly due to the lack of RFRP2-specific antibodies or rapid turnover of the peptide that prevents
detection by mass spectrometry, making this study the first demonstration of in vivo biological activ-
ity of RFRP2. Furthermore, the receptor(s) that bind RFRP2 remain unknown. Taken together, these
observations suggest that RFRP2 affects sleep via an unidentified receptor that is expressed in cells
along the brain ventricle lining.
Third, our data suggests that NPVF neurons may regulate the processing of sensory information
during sleep. This is important because, while a hallmark of sleep is reduced reactivity to sensory
stimuli, the underlying mechanism is unclear. Surprisingly, we found that optogenetic stimulation of
NPVF neurons is correlated with suppression of neuronal activity in the tectum, a brain region
involved in visual processing, to levels similar to those normally observed at night. Consistent with
this result, we observed that NPVF neurons extend projections to the tectum (Figure 5—figure sup-
plement 1A) suggesting that NPVF neurons may directly regulate neurons in the tectum. Such a
mechanism would be surprising because vertebrate sensory systems are thought to be activated sim-
ilarly during sleep and wake states, with the thalamus limiting responses to these stimuli during sleep
(Coulon et al., 2012). Our data suggests that sleep-promoting mechanisms may act upstream of the
thalamus to inhibit brain regions that receive direct input from sensory systems. Similarly, decreased
arousal during sleep stems in part from reduced responsiveness of sensory systems in C.
elegans (Cho and Sternberg, 2014; Schwarz et al., 2011).
Finally, we observed that inhibition of NPVF signaling and ablation of NPVF neurons impair both
the initiation and maintenance of sleep, hallmark characteristics of insomnia (Mahowald and
Schenck, 2005). The mechanisms underlying insomnia remain poorly understood, and our data sug-
gests a novel potential mechanism. RFRP peptides are thought to act via GPCRs (Findeisen et al.,
2011; Hinuma et al., 2000), which are highly amenable to small molecule manipulation, and over a
quarter of FDA-approved drugs target this protein class (Overington et al., 2006). The NPVF sys-
tem thus provides an attractive therapeutic target for sleep disorders. The development of drugs
that target specific sleep regulators is important because most commonly prescribed sleep aids are
GABA receptor agonists, and thus are relatively non-specific for sleep, in addition to having signifi-
cant side effects (Rihel and Schier, 2013). The increased efficacy and minimal side effects of recently
developed Hcrt receptor antagonists has shown the potential benefits of targeting a more specific
sleep regulatory pathway (Krystal, 2015). Thus, NPVF receptor antagonists could be useful for treat-
ing chronic sleepiness, whereas agonists could be useful to treat insomnia.
In summary, we have shown that NPVF signaling and NPVF neurons comprise a novel vertebrate
sleep promoting system. Taken together with roles for RFamide neuropeptides in invertebrate sleep,
our results suggest that these peptides participate in an ancient and central sleep regulatory mecha-
nism. Our results redefine the likely functions of vertebrate RFamide neuropeptides and suggest
that further comparative studies of RFamide neuropeptides may reveal common principles underly-
ing the regulation of sleep/wake states in the animal kingdom.
Materials and methods
Key resources table
Reagent type or
resource Designation Source or reference Identifiers Additional information
gene (Danio rerio) npvf PMID: 26687719 ZDB-GENE-
070424–226
gene (Caenorhabditis
elegans)
flp-13 PMID: 19910365 CELE_F33D4.3;
WBGene00001456
Continued on next page
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Continued
Reagent type or
resource Designation Source or reference Identifiers Additional information
genetic reagent
(D. rerio)
Tg(hs:NPVF) this paper ct846Tg; RRID:
ZDB-ALT-170927-2
zebrafish npvf open reading
frame cloned downstream of the
zebrafish hsp70c promoter
genetic reagent
(D. rerio)
Tg(hs:RFRP1) this paper ct854Tg; RRID:
ZDB-ALT-171004-1
NPVF transgene cloned downstream
of the zebrafish hsp70c promoter,
but with the amino acid sequence of
RFRP2 and RFRP3 scrambled to
abolish peptide function
genetic reagent
(D. rerio)
Tg(hsp:RFRP2) this paper ct855Tg; RRID:
ZDB-ALT-171004-2
NPVF transgene cloned downstream
of the zebrafish hsp70c promoter,
but with the amino acid sequence of
RFRP1 and RFRP3 scrambled to
abolish peptide function
genetic reagent
(D. rerio)
Tg(hs:RFRP3) this paper ct856Tg; RRID:
ZDB-ALT-171004-3
NPVF transgene cloned downstream
of the zebrafish hsp70c promoter,
but with the amino acid sequence of
RFRP1 and RFRP2 scrambled to
abolish peptide function
genetic reagent
(D. rerio)
Tg(hs:RFRP1,2) this paper ct857Tg; RRID:
ZDB-ALT-171004-4
NPVF transgene cloned downstream
of the zebrafish hsp70c promoter,
but with the amino acid sequence of
RFRP3 scrambled to abolish
peptide function
genetic reagent
(D. rerio)
Tg(hs:RFRP1,3) this paper ct858Tg; RRID:
ZDB-ALT-171004-5
NPVF transgene cloned
downstream of the zebrafish
hsp70c promoter, but with the
amino acid sequence of RFRP2
scrambled to abolish peptide function
genetic reagent
(D. rerio)
Tg(hs:RFRP2,3) this paper ct859Tg; RRID:
ZDB-ALT-171004-6
NPVF transgene cloned
downstream of the zebrafish
hsp70c promoter, but with the
amino acid sequence of RFRP1
scrambled to abolish peptide function
genetic reagent
(D. rerio)
Tg(hs:RFRPscr) this paper ct860Tg; RRID:
ZDB-ALT-171004-7
NPVF transgene cloned
downstream of the zebrafish
hsp70c promoter, but with the
amino acid sequence of RFRP1,
RFRP2, and RFRP3 scrambled
to abolish peptide function
genetic reagent
(D. rerio)
Tg(hs:FLP-13) this paper C. elegans flp-13 open
reading frame cloned
downstream of the zebrafish
hsp70c promoter
genetic reagent
(D. rerio)
npvf mutant this paper ct845; RRID:
ZDB-ALT-170927-1
mutant contains a 7 bp
deletion after nucleotide
324 of the open reading
frame; premature stop
codon after amino acid 146
genetic reagent
(D. rerio)
Tg(npvf:EGFP) this paper ct847Tg; RRID:
ZDB-ALT-170927-3
npvf promoter cloned
upstream of enhanced
green fluorescent
protein (EGFP)
genetic reagent
(D. rerio)
Tg(npvf:KalTA4) this paper ct848Tg; RRID:
ZDB-ALT-170927-4
npvf promoter cloned
upstream of KalTA4
genetic reagent
(D. rerio)
Tg(npvf:ReaChR-
mCitrine)
this paper ct849Tg; RRID:
ZDB-ALT-170927-5
npvf promoter cloned
upstream of ReaChR-mCitrine
genetic reagent
(D. rerio)
Tg(npvf:mTagYFP-
T2A-eNTR)
this paper ct850Tg; RRID:
ZDB-ALT-170927-6
npvf promoter cloned
upstream of mTagYFP-T2A-
enhanced nitroreductase
Continued on next page
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Reagent type or
resource Designation Source or reference Identifiers Additional information
genetic reagent
(D. rerio)
Tg(UAS:TRPV1-
TagRFP-T;
cmlc2:EGFP)
this paper ct851Tg; RRID:
ZDB-ALT-170927-7
UAS promoter cloned
upstream of TRPV1-TagRFP-T
genetic reagent
(D. rerio)
Tg(elavl3:H2B-
GCaMP6s)
PMID: 25068735 jf5Tg; RRID: ZDB-ALT-141023-2
antibody anti-GFP (Chicken
polyclonal)
Aves Laboratories Cat#: GFP-1020;
RRID: AB_10000240
1:400
antibody anti-TagRFP (Rabbit
polyclonal)
Evrogen Cat#: AB233
RRID: AB_2571743
1:100
antibody anti-dsRed (Rabbit
polyclonal)
Takara Clonetech Cat#: 645496 1:400
antibody anti-digoxigenin
Fab fragments
(Sheep polyclonal)
Sigma-Aldrich Cat#: 11093274910;
RRID: AB_514497
1:2000
antibody Alexa 488- or 568-
secondaries
Molecular Probes 1:500
sequence-based
reagent
Primers for genotyping this paper See Materials and Methods
sequence-based
reagent
Primers for qPCR this paper See Materials and Methods
sequence-based
reagent
Primers for riboprobe
synthesis
this paper See Materials and Methods
sequence-based
reagent
Oligonucleotides used
to generate npvf
CRISPR mutant
this paper See Materials and Methods
peptide, recombinant
protein
RF9 Tocris Cat #: 3672
peptide, recombinant
protein
GJ-14 PMID: 26259035 Anaspec, Inc;
custom synthesis
peptide, recombinant
protein
Normal Goat Serum Thermo Fisher Scientific Cat# NC9660079
commercial assay
or kit
DIG RNA Labeling Kit Sigma-Aldrich Cat#: 11175025910
commercial assay
or kit
TSA Plus Cyanine 3
and Fluorescein System
PerkinElmer Cat#: NEL753001KT
commercial assay
or kit
FirstChoice RLM-RACE Thermo Fisher Scientific Cat#: AM1700
commercial assay
or kit
SuperScript III
First-Strand Synthesis
System
Thermo Fisher Scientific Cat#: 18080051
chemical
compound, drug
16% paraformaldehyde Thermo Fisher Scientific Cat#: 15710
chemical
compound, drug
NBT/BCIP Stock Solution Thermo Fisher Scientific Cat#: 11681451001
chemical
compound, drug
SYBR Green PCR
Master Mix
Thermo Fisher Scientific Cat#: 4364346
software, algorithm Excel Microsoft https://office.
microsoft.com/excel/
software, algorithm Fiji PMID: 22732772 https://fiji.sc;
RRID: SCR_002285
software, algorithm GraphPad Prism6 GraphPad Software http://www.graphpad.com/;
RRID: SCR_002798
software, algorithm MATLAB MathWorks https://www.
mathworks.com/
Continued on next page
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Reagent type or
resource Designation Source or reference Identifiers Additional information
software, algorithm Principal Component
and Independent
Component Analysis
PMID: 19778505 Automated analysis of
cellular signals from large-scale
calcium imaging data.
software, algorithm Videotracking
script for
behavioral analysis
PMID: 17182791 Source code attached
software, algorithm Arousal threshold
script for
behavioral analysis
PMID: 26374985 Source code attached
other 96-well plate for
behavioral experiments
GE Healthcare
Life Sciences
Cat#: 7701–1651
other MicroAmp Optical
Adhesive Film
Thermo Fisher Scientific Cat#: 4311971
Zebrafish genetics
Zebrafish were raised on a 14:10 h light:dark cycle at 28.5˚C, with lights on at 9 a.m. and off at 11 p.
m., unless specified otherwise. Wild-type (WT), transgenic, and mutant stocks come from a back-
ground of TL X AB strains. All experiments were performed using standard protocols (Wester-
field, 1993) in accordance with the California Institute of Technology and University of Southern
California Institutional Animal Care and Use Committee guidelines.
Generation of transgenic lines
Tg(hs:NPVF)
Full-length zebrafish npvf cDNA was isolated using 5’ and 3’ RACE (FirstChoice RLM-RACE, Ambion)
and the open reading frame was cloned downstream of the zebrafish hsp70c promoter
(Halloran et al., 2000) in a vector containing flanking I-SceI meganuclease sites. We generated sta-
ble transgenic animals by injecting plasmids with I-SceI (New England Biolabs Inc.) into the cell of
embryos at the one-cell stage (Thermes et al., 2002). To identify transgenic founders, we out-
crossed potential founders, performed a heat shock on their larval progeny at 5 dpf, and then per-
formed npvf ISH. At least three lines that produced strong and ubiquitous overexpression, and
lacked pre-heat shock expression, were selected and tested for behavioral phenotypes. Tg(hs:
NPVF) transgenic animals (ct846Tg, RRID: ZDB-ALT-170927-2) were identified by PCR using the pri-
mers 5’-GCACACCTGAATCACCATCA-3’ and 5’-GGTTTGTCCAAACTCATCAATGT-3’ with a prod-
uct size of 206 bp.
Heat-shock inducible npvf transgenes containing scrambled RFRP peptides
We identified RFRP peptides based on homology to the mammalian (Ubuka and Tsutsui, 2014) and
goldfish (Sawada et al., 2002) peptides. We generated transgenes in which the amino acid
sequence of one or more peptide was scrambled to abolish peptide function. We verified that
scrambled peptides were distinct from endogenous zebrafish peptides using BLASTp
(Altschul et al., 1997) and selected codons based on codon usage frequencies in the zebrafish
genome (Horstick et al., 2015). Transgenes were assembled using double-stranded DNA gBlocks
(Integrated DNA Technologies) and Gibson assembly (Gibson et al., 2009). Stable lines for Tg(hs:
RFRP1) (ct854Tg, RRID: ZDB-ALT-171004-1), Tg(hs:RFRP2) (ct855Tg, RRID: ZDB-ALT-171004-2), Tg
(hs:RFRP3) (ct856Tg, RRID: ZDB-ALT-171004-3), Tg(hs:RFRP1,2) (ct857Tg, RRID: ZDB-ALT-171004-
4), Tg(hs:RFRP1,3) (ct858Tg, RRID: ZDB-ALT-171004-5), Tg(hs:RFRP2,3) (ct859Tg, RRID: ZDB-ALT-
171004-6), and Tg(hs:RFRPscr) (ct860Tg, RRID: ZDB-ALT-171004-7) were generated and isolated as
described for Tg(hs:NPVF). The presence of any npvf transgene was confirmed by PCR using the
NPVF primers 5’-GCACACCTGAATCACCATCA-3’ and 5’-GGTTTGTCCAAACTCATCAATGT-3’ with
a product size of 206 bp. Fish containing transgenes with specific scrambled RFRP peptides were
identified by PCR using the primers: RPRP1 scrambled: 5’-CTTCGCTCTTCTTTCTTTAGCC-3’ and 5’-
AGTGAAGTGGAGCGTGCAAT-3’ (266 bp product); RFRP2 scrambled: 5’-CTTCGCTCTTCTTTC
TTTAGCC-3’ and 5’-GATCTTCGTGGACGCGTCGAA-3’ (349 bp product); RFRP3 scrambled: 5’-C
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TTCGCTCTTCTTTCTTTAGCC-3’ and 5’-TGCAGGGGTTGAGAACTGA-3’ (415 bp product). As an
example, a Tg(hs:RFRP2) animal would produce PCR products using NPVF primers (206 bp), RFRP1
scrambled primers (266 bp), and RFRP3 scrambled primers (415 bp), and would not produce a PCR
product using RFRP2 scrambled primers.
Tg(hs:FLP-13)
The C. elegans flp-13 open reading frame was amplified from a cDNA library from the C. elegans
strain PS6845, and cloned downstream of the zebrafish hsp70c promoter (Halloran et al., 2000) in a
vector containing flanking I-SceI meganuclease sites. We generated stable transgenic animals by
injecting plasmid with I-SceI (New England Biolabs, Inc.) into the cell of embryos at the one-cell
stage (Thermes et al., 2002). To identify transgenic founders, we outcrossed potential founders,
performed a heat shock on their larval progeny at 5 dpf, and then performed ISH using a flp-13 spe-
cific probe. A line that produced strong and ubiquitous overexpression in the brain was used for
behavioral phenotypes. Transgenic animals were identified by PCR using the primers 5’-ATGA
TGACGTCACTGCTCACTATC 3’ and 5’-GGTTTGTCCAAACTCATCAATGT 3’ with a product size
of 554 bp.
npvf mutant
The npvf mutant (ct845Tg, RRID: ZDB-ALT-170927-1) was generated using CRISPR/Cas9 as
described (Hwang et al., 2013), with the sgRNA target sequence 5’-GGGAGGTTGATGGTAGACTT-
3’. The mutant contains a 7 bp deletion (CCCAAGT) after nucleotide 324 of the open reading frame.
The mutation results in a change in reading frame after amino acid 108 and a premature stop codon
after amino acid 146, compared to 198 amino acids for the WT protein. The predicted mutant pro-
tein lacks the RFRP2 and RFRP3 peptide sequences. Mutant animals were genotyped using the pri-
mers 5’-CAGTGGTGGTGCGAGTTCT-3’ and 5’-GCTGAGGGAGGTTGATGGTA-3’, which produce a
151 bp or 144 bp band for the WT or mutant allele, respectively. npvf heterozygous mutants were
outcrossed to the parental TLAB strain for three generations before use in behavioral experiments.
npvf mutants are homozygous viable and fertile, and are morphologically indistinguishable from WT
animals.
Tg(npvf:EGFP) and Tg(npvf:KalTA4)
A 3.9 kb region of genomic DNA immediately 5’ to the npvf start codon was amplified from zebra-
fish genomic DNA using the primers 5’-TGACTGAAGTAGAAAATCAGCCTTT-3’ and 5’-CTTACAA
TCGGTCACTGAAGGC-3’ and Pfu Ultra II Fusion HS DNA Polymerase (Agilent Technologies). This
sequence was subcloned downstream of 2 copies of a neuron-restrictive silencing element (NRSE)
(Bergeron et al., 2012; Xie et al., 2012) and upstream of enhanced green fluorescent protein
(EGFP) or KalTA4 (Distel et al., 2009) in a vector containing flanking I-SceI meganuclease sites using
Gibson assembly to generate Tg(npvf:EGFP) (ct847Tg, RRID: ZDB-ALT-170927-3) and Tg(npvf:
KalTA4) (ct848Tg,RRID:ZDB-ALT-170927-4) animals. Stable transgenic lines were generated using
the I-SceI method (Thermes et al., 2002). Tg(npvf:KalTA4) animals were identified by PCR using the
primers 5’-ATGCAAAGCTGTGAGTGCAT-3’ and 5’-TTGTGAGTGGACTTCGCTTG-3’ (270 bp
product).
Tg(npvf:ReaChR-mCitrine) and Tg(npvf:mTagYFP-T2A-eNTR)
Using Gibson assembly (Gibson et al., 2009), the 3.9 kb npvf promoter was cloned upstream of
ReaChR (Lin et al., 2013) fused to mCitrine, and upstream of mTagYFP-T2A-enhanced nitroreduc-
tase (eNTR) (Mathias et al., 2014; Tabor et al., 2014), in a vector containing NSRE elements and
flanking I-SceI meganuclease sites. The npvf:mTagYFP-T2A-eNTR transgene contains a Gap43 palmi-
toylation sequence that targets TagYFP to the membrane, and a T2A sequence, which generates a
self-cleaving peptide (Donnelly et al., 2001), was inserted between mTagYFP and eNTR to produce
stoichiometric levels of each protein. Stable transgenic lines were generated using the I-SceI method
(Thermes et al., 2002). Transgenic animals were identified using fluorescence or by PCR using the
primers: ReaChR: 5’-CACGAGAGAATGCTGTTCCA-3’ and 5’-CCATGGTGCGTTTGCTATAA-3’ (450
bp product); eNTR: 5’-ATGCAAAGCTGTGAGTGCAT-3’ and 5’-CTCGCCTTTGCTAACCATTG-3’
(227 bp product). For simplicity, Tg(npvf:ReaChR-mCitrine) (ct849Tg, RRID: ZDB-ALT-170927-5) is
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referred to as Tg(npvf:ReaChR), and Tg(npvf:mTagYFP-T2A-eNTR) (ct850Tg, RRID: ZDB-ALT-
170927-6) is referred to as Tg(npvf:eNTR), in the figures.
Tg(UAS:TRPV1-TagRFP-T;cmlc2:EGFP)
We generated the Tg(UAS:TRPV1-TagRFP-T;cmlc2:EGFP) transgenic line (ct851Tg, RRID: ZDB-ALT-
170927-7) using the Tol2kit (Kwan et al., 2007) and multisite Gateway Technology (Invitrogen). The
middle entry clone (pME-TRPV1-TagRFP-T) was generated using a BP reaction by combining a donor
vector (pDONR221) and TRPV1-TagRFP-T (Chen et al., 2016c). The LR reaction was performed by
combining the 5’ (p5E-UAS), middle (pME-TRPV1-TagRFP-T), and 3’ (p3E-polyA) entry clones into
the destination vector (pDestTol2CG2). Stable transgenic lines were generated by injecting the plas-
mid and tol2 transposase mRNA into embryos at the 1 cell stage. Transgenic animals were identified
by EGFP expression in the heart or by PCR using the primers 5’-CAGCCTCACTTTGAGCTCCT-3’
and 5’-TCCTCATAAGGGCAGTCCAG-3’ (349 bp product). For simplicity, Tg(UAS:TRPV1-TagRFP-T;
cmlc2:EGFP) is referred to as Tg(UAS:TRPV1) in the figures.
Tg(elavl3:H2B-GCaMP6s); nacre fish were a kind gift from Misha Ahrens (Vladimirov et al.,
2014).
Zebrafish behavioral assays
Locomotor activity assay
Individual larvae were placed into each well of a 96-well plate (7701–1651, Whatman) containing 650
mL of E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7.4). The
only exception was the chemogenetic ablation experiment, in which animals were placed into the
96-well plate after metronidazole treatment. Plates were sealed with an optical adhesive film
(4311971, Applied Biosystems) to prevent evaporation. The sealing process introduces air bubbles in
some wells, which are discarded from analysis. Animals were blindly assigned a position in the plate
and were genotyped by PCR after the behavioral experiment was complete. The only exception to
this setup was the experiment in which +/+, Tg(hs:RFRP)/+, and Tg(hs:RFRP)/Tg(hs:RFRP) animals
were compared. Because we could not distinguish between heterozygous and homozygous trans-
genic animals using the PCR genotyping assay, homozygous Tg(hs:RFRP) cousins were placed into
interleaving rows of a plate that also contained blindly assigned +/+ and Tg(hs:RFRP)/+ siblings,
which were identified by PCR following the experiment. Locomotor activity was monitored using an
automated videotracking system (Viewpoint Life Sciences) with a Dinion one-third inch monochrome
camera (Dragonfly 2, Point Grey) fitted with a fixed-angle megapixel lens (M5018-MP, Computar)
and infrared filter. For heat shock-induced overexpression experiments, larvae were heat shocked at
37˚C for 1 hr starting at 12 p.m., 3 p.m., 4 p.m., or 9:45 p.m. at 5 dpf. The movement of each larva
was captured at 15 Hz and recorded using the quantization mode with 1 min time bins. The 96-well
plate and camera were housed inside a custom-modified, Zebrabox (Viewpoint Life Sciences) that
was continuously illuminated with infrared LEDs, and illuminated with white LEDs from 9 a.m. to 11
p.m., except as noted in LL or DD experiments. The 96-well plate was housed in a chamber filled
with recirculating water to maintain a constant temperature of 28.5˚C. The parameters used for
detection were: detection threshold, 15; burst, 29; freeze, 3, which were determined empirically.
Data were processed using custom PERL and Matlab (The Mathworks, Inc.) scripts, and statistical
tests were performed using Prism (GraphPad) for ANOVA analysis and Excel (Microsoft) for two-
tailed Student’s t-test.
A movement was defined as a pixel displacement between adjacent video frames preceded and
followed by a period of inactivity of at least 67 ms (the limit of temporal resolution). Any one-minute
period with no movement was defined as one minute of sleep based on arousal threshold changes
(Prober et al., 2006). A sleep bout was defined as a continuous string of sleep minutes. Sleep
latency was defined as the length of time from lights on or off to the start of the first sleep bout.
Average activity was defined as the average amount of activity in seconds/hour, including sleep
bouts. Average wake activity was defined as the average amount of activity in seconds/hour, exclud-
ing sleep bouts.
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Arousal threshold assay
We modified the videotracking system by adding an Arduino-based automated driver to control two
solenoids (28P-I-12, Guardian Electric) that delivered a tap to a 96-well plate containing larvae
(Singh et al., 2015). This setup allowed us to drive the solenoids with voltage ranging from 0 V to
20 V over a range of 4095 settings (from 0.01 to 40.95). We used taps ranging from a power setting
of 1–36.31. Taps of 14 different intensities were applied in a random order with an inter-trial-interval
of 1 min during the day and night for Tg(hs:NPVF) and RF9/GJ-14 experiments, respectively. Previ-
ous studies showed that a 15 s interval between repetitive stimuli is sufficient to prevent behavioral
habituation (Burgess and Granato, 2007; Woods et al., 2014). The background probability of
movement was calculated by identifying for each genotype the fraction of larvae that moved 5 s
prior to all stimuli delivered during an experiment (14 different tap powers x 30 trials per experi-
ment = 420 data points per larva). This value was subtracted from the average response fraction
value for each tap event. The response of larvae to the stimuli was monitored using the videotrack-
ing software and was analyzed using Matlab and Excel. Statistical analysis was performed using the
Variable Slope log(dose) response curve fitting module of Prism.
Optogenetic behavioral assay
The videotracking system was modified to include a custom array containing blue LEDs (470 nm,
MR-B0040-10S, Luxeon V-star) mounted 15 cm above and 7 cm away from the center of the 96-well
plate to ensure uniform illumination (Singh et al., 2015). The LEDs were controlled using a custom-
built driver and software written in BASIC stamp editor. A power meter (1098293, Laser-check) was
used before each experiment to verify uniform blue light intensity (~400 mW at the surface of the 96-
well plate). During the afternoon of 5 dpf, single larvae were placed into each well of a 96-well plate
as described above and placed in the videotracker in the dark for 7 h. Larvae were then exposed to
blue light for 30 min, starting at 12 a.m. Three trials were performed during the night, with an inter-
trial interval of 3 hr. Total activity for each larva was monitored for 30 min before and after light
onset, with data collected in 10 s bins. Light onset caused a burst of locomotor activity lasting
for ~30 s for all genotypes, so data obtained during the minute before and after light onset was
excluded from analysis. A large burst of locomotor activity was also observed for all genotypes when
the lights were turned off after the 30 min illumination period. This data was excluded from analysis
and is not shown in the figures. The total amount of locomotor activity of each larva during the 30
min of light exposure, excluding the minute after light onset, was divided by the average baseline
locomotor activity for all larvae of the same genotype. The baseline period was defined as 30 min
before light onset, excluding the minute before light onset. Data from three independent experi-
ments were pooled and converted to percentage of WT larvae.
Chemogenetic behavioral assay
Neuronal activation using TRPV1 was performed as described (Chen et al., 2016c) with some modifi-
cations. Animals generated by mating homozygous Tg(npvf:KalTA4) to heterozygous Tg(UAS:
TRPV1-TagRFP-T) fish were immersed in either DMSO (4948–02, Macron Chemicals) vehicle control
or 2 mM capsaicin at 100 h post-fertilization (hpf). Capsaicin powder (M2028, Sigma) was dissolved in
DMSO to prepare a 100 mM stock solution that was stored in aliquots at  20˚C. Capsaicin working
solutions were prepared just before each experiment by diluting the stock solution in E3 medium.
All treatments contained a final concentration of 0.002% DMSO. Behavioral analysis was performed
from 6 dpf until 8 dpf. Larvae were then genotyped by PCR to identify Tg(npvf:KalTA4); Tg(UAS:
TRPV1-TagRFP-T) and Tg(npvf:KalTA4) animals.
Metronidazole (MTZ) induced neuronal ablation
Neuronal ablation using eNTR was performed as described (Gandhi et al., 2015) with some modifi-
cations. Heterozygous fish from a Tg(npvf:mTagYFP-T2A-eNTR) line that exhibits strong YFP fluores-
cence in NPVF neurons were outcrossed to WT fish. Embryos were raised in E3 medium until 60 hpf,
at which point they were treated with 5 mM MTZ (46461, Sigma Aldrich) in 0.2% DMSO in E3
medium for 60 h (60–120 hpf), with the MTZ solution refreshed every ~20 h. Larvae were then rinsed
twice with E3 medium (120–122 hpf) and maintained in E3 medium for ~8 hr. MTZ treated Tg(npvf:
mTagYFP-T2A-eNTR) and WT siblings were then placed into 96-well plates and allowed to recover
Lee et al. eLife 2017;6:e25727. DOI: https://doi.org/10.7554/eLife.25727 24 of 35
Research article Neuroscience
from MTZ treatment for 24 h. Behavioral analysis was performed from 6 dpf at night until 8 dpf at
night. Larvae were then genotyped by PCR to identify transgenic and WT animals. To quantify MTZ-
induced neuronal ablation, Tg(npvf:mTagYFP-T2A-eNTR) and WT siblings were fluorescently sorted
at 2 dpf, treated with either MTZ or DMSO vehicle as described above, and then processed at 7 dpf
for ISH using a DIG-labeled npvf-specific probe as described below.
Scripts used for analysis of behavioral data
sort_fish_sttime_192.pl is a Perl script (Prober et al., 2006) that converts data acquired by the View-
point videotracker system to a format that is useful for analysis using Matlab and removes notations
that are not relevant to behavioral analysis. perl_batch_192well.m is a Matlab script that allows the
sort_fish_sttime_192.pl script to run on the Matlab platform. TapAnalysis.m is a Matlab script that
analyzes tapping assay data and generates a table that lists the number of larvae that moved during
each tapping event. VT_analysis.m is a Matlab script (modified from [Prober et al., 2006]) that ana-
lyzes data collected by the Viewpoint videotracker system to quantify several metrics, including loco-
motor activity, wake activity, sleep, sleep architecture and sleep latency. These scripts and detailed
instructions on their use will be provided upon request.
Histology
In situ hybridization (ISH)
Samples were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) for approxi-
mately 16 h at room temperature. ISH was performed using digoxygenin (DIG) labeled antisense
riboprobes (DIG RNA Labeling Kit, Roche) as previously described (Thisse and Thisse, 2008). Dou-
ble-fluorescent ISH (FISH) was performed using DIG- and fluorescein-labeled riboprobes and the
TSA Plus Fluorescein and Cyanine 3 Systems kit (Perkin Elmer). Probes specific for npvf (Tessmar-
Raible et al., 2007), vesicular glutamate transporter 2a (vglut2a), vglut2b, and glutamate decarbox-
ylase 67 (gad67) (Higashijima et al., 2004) have been described. The c-fos probe was transcribed
using a PCR product amplified from a zebrafish cDNA library using the primers Forward: 5’-CAGC
TCCACCACAGTGAAGA-3’ and Reverse: 5’-TGCAAACAATTCGCAAGTTC-3’, and then serially
amplified with the same forward primer and a T7 sequence added to the Reverse Primer: 5’-GAA
TTGTAATACGACTCACTATAGGGTGCAAACAATTCGCAAGTTC-3’.
Immunohistochemistry
Samples were fixed in 4% PFA in PBS overnight at 4˚C and then washed with 0.25% Triton X-100/
PBS (PBTx). Brains were manually dissected and blocked for at least 1 h in 2% goat serum/2%
DMSO/PBTx at room temperature or overnight at 4˚C. Antibody incubations were performed in
blocking solution overnight at 4˚C using chicken anti-GFP (1:400, GFP-1020, Aves Labs), rabbit anti-
TagRFP (1:100, AB233, Evrogen), or rabbit anti-dsRed (1:400, 643496, Takara Clontech) primary anti-
bodies, and Alexa Fluor 488 and 568 secondary antibodies (1:500, Life Technologies). Samples were
mounted in 50% glycerol/PBS and imaged using a Zeiss LSM 780 confocal microscope. Quantifica-
tion of neurons (Figure 5—figure supplement 2M and Figure 6C) and c-fos intensity per NPVF neu-
ron (Figure 5—figure supplement 2G) was performed blind prior to genotyping.
Pharmacology
RF9 (3672; Tocris) was dissolved in DMSO and then added to E3 medium for a final concentration of
0.1% DMSO and 10 mM RF9. Drug solution was freshly prepared prior to each experiment. Controls
were exposed to 0.1% DMSO alone. RF9 and DMSO vehicle were loaded into separate sides of a
96-well plate with an empty row in between. WT larvae from the same clutch were added to the
plate, and plates were sealed with an optical adhesive film (4311971, Applied Biosystems) to prevent
evaporation.
GJ-14 (Diphenylacetamide-D-Arg-D-Phg-NH2) was custom synthesized by AnaSpec, Inc. (Fre-
mont, CA) as previously described (Kim et al., 2015). Residual TFA was removed and exchanged
with acetate salt. Purity was verified by HPLC, found to be 99% around the peak area, and subse-
quently lyophilized. GJ-14 was reconstituted in DMSO, and then added to E3 medium for a final
concentration of 0.05% DMSO and 10 mM GJ-14. Drug solution was freshly prepared prior to each
experiment and behavioral experiments were performed as described for RF9.
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qPCR
Larval zebrafish were raised on a 14:10 h light:dark cycle at 28.5˚C with lights on at 9 a.m. and off at
11 p.m. At 5 dpf, total RNA was collected using Trizol reagent (15596–026, Life Technologies) from
20 pooled larvae every 6 h for 36 h. cDNA was synthesized from 5 mg of total RNA using Superscript
III Reverse Transcriptase (18080–051, Invitrogen) and quantitative PCR was carried out using SYBR
green master mix (4364346, Life Technologies) in an ABI PRISM 7900HT (Life Technologies) instru-
ment using the primers 5’-GGCTCTCAGATTGCCACTTT-3’ and 5’-GGGGCCACATTAAGAGTGAA-
3’. ribosomal protein l13a (rpl13a) was used as a reference gene, using the primers 5’-TCTGGAG-
GACTGTAAGAGGTATGC-3’ and 5’-AGACGCACAATCTTGAGAGCAG-3’. Relative expression levels
were determined by using the DDCt method (Livak and Schmittgen, 2001), normalized to the high-
est Ct value for each gene.
Imaging
Confocal and brightfield imaging
Dissected brains were coverslip mounted in Vectashield (H-1000, Vector Labs) or 80% glycerol in
PBS and imaged using a compound microscope (Axioimager with EC Plan-Neofluar 10x/0.30 NA air
objective or Plan-Apochromat 20x/0.8 NA air objective, Zeiss) for chromogenic ISH samples, or for
double fluorescent ISH samples, a confocal microscope (LSM 780 with Plan-Apochromat 10x/0.45
NA air objective, LD LCI Plan-Apochromat 25x/0.8 NA Imm Corr objective, or LD C-Apochromat
40x/1.1 NA water objective, Zeiss). Fluorescein and cyanine were imaged in separate channels with
488 nm and 561 nm lasers, respectively. Confocal images are displayed as the maximum intensity
z-projection of a stack of optical sections of approximately one airy unit (A.U.) thickness.
Two-photon selective plane illumination microscopy (2P-SPIM)
Live imaging was performed using a custom built 2P-SPIM microscope (Truong et al., 2011) with
940 nm excitation pulsed laser light (Chameleon Ultra 2, Coherent), focused by spherical optics
(Nikon MRH07120, 10x, NA = 0.3), yielding a focused beam waist of approximately 4 mm, with total
power of 50 mW. Fluorescence signal was collected by a water-immersion objective (Nikon
MRD77220, 25x, NA = 1.1 for data shown in Figure 7 and Figure 7—figure supplement 1, Olympus
XLUMPLFLN-W, 20x, NA = 1.0 for data shown in Figure 7—figure supplement 2), sCMOS camera
(Hamamatsu ORCA-Flash 4.2), and appropriate spectral filters (Semrock). To increase the signal-to-
noise ratio, we used a tube lens of focal length = 100 mm (Thorlabs AC508-1000-A-NK) to yield a 2x
de-magnification. Image acquisition was performed using MicroManager software (Edelstein et al.,
2014), with 2x binning, 950 ms exposure time.
Larvae were raised in a light:dark cycle, with dim white lights on from 9 a.m. to 10 p.m., for 4–7
days in order to entrain circadian rhythms. At ~20 hpf, 1-phenyl-2-thiourea (PTU) (30 mg/L) was
added to reduce pigmentation. One h prior to imaging, larvae were anesthetized with tricaine (100
mg/L) and embedded in 1.5% low-melting point agarose (SeaPlaque), then mounted in the imaging
chamber filled with 35 mL of 0.3x Danieau Buffer (1740 mM NaCl, 21 mM KCl, 12 mM MgSO4.7H2O,
18 mM Ca(NO3)2, 150 mM HEPES) at 28˚C without anesthetic, and allowed to recover for at least 30
min. Live imaging was performed with the focal plane set at depth of ~70 mm from the dorsal surface
of the brain.
For results presented in Figure 7A–D, Tg(elavl3:H2B-GCaMP6s) animals were entrained for 4.5
days, mounted for imaging at 5 dpf in the evening, and then imaged in 2 min sessions every 15 min
for up to 36 h in constant dark. Intrinsic activity and light-evoked responses were used to assess
putative sleep or wake states. Each 2 min session consisted of three stages that recorded: (1) intrin-
sic neural activity for 30 s, after which (2) a 625 nm LED (Thorlabs M625L3) was turned on and slowly
increased in intensity for 60 s, achieving a final intensity of 0.1 mW/cm2 at the sample, after which (3)
the LED was abruptly turned off and imaging continued for an additional 30 s. Using this approach,
we recorded both intrinsic activity and activity evoked by onset and offset of an arousing light
stimulus.
For results presented in Figure 7E–H and Figure 7—figure supplement 1, in order to test the
hypothesis that stimulation of NPVF neurons induces neuronal activity that is similar to that observed
during subjective night, we optogenetically stimulated NPVF neurons using Tg(npvf:ReaChR-mCi-
trine);Tg(elavl3:H2B-GCaMP6s);nacre/nacre larvae, with Tg(elavl3:H2B-GCaMP6s);nacre/nacre
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siblings as controls. Animals were entrained up to the day of imaging, at 5 or 6 dpf. Imaging was
performed in 2 min sessions every 5 min using the same settings and region of interest as for record-
ing brain activity during natural sleep and wake. Baseline neural activity was established in five imag-
ing trials (25 min). A ReaChR-activating 625 nm LED (Thorlabs M625L3) was then turned on and
another 10 imaging trials were performed. The activating light had intensity of 10 mW/cm2, slightly
focused with beam waist of ~2 mm at the sample, covering the entire head of the animal. Imaging
data was collected blinded to genotype, and posthumous PCR genotyping was performed as
described above.
Image analysis for Figure 7 and Figure 7—figure supplement 1 was performed using ImageJ
(NIH). Background signal due to camera dark counts and residual light from the 625 nm LED was
subtracted. For all quantitative analyses, the fluorescence signal was averaged over a region of inter-
est of the optic tectum (Figure 7A). Fluorescent signal intensity is plotted as F in Figure 7A and as
DF = F – F0 in Figure 7B and D, where the baseline F0 = lowest signal measured across the entire
subjective day/subjective night recording period. In Figure 7C, signal is normalized by
FN = averaged signal of intrinsic activity during subjective day. In Figure 7E–H, the signal for each
animal is calculated with baseline F0 = averaged signal over the first five trials, then normalized by
FN = peak of signal after red light is turned on, for the same animal. The steady-state value shown in
Figure 7H was calculated by averaging the normalized signal over the last six trials (trials 10–15).
For results presented in Figure 7—figure supplement 2, in order to test the hypothesis that che-
mogenetic stimulation of NPVF neurons affects neuronal activity in a manner expected for increased
sleep at night, as expected based on results from the behavioral assay (Figure 5—figure supple-
ment 2), we chemogenetically stimulated NPVF neurons in Tg(npvf:KalTA4);Tg(UAS:TRPV1-TagRFP-
T);Tg(elavl3:H2B-GCaMP6s);nacre/nacre larvae and their Tg(npvf:KalTA4);Tg(elavl3:H2B-GCaMP6s);
nacre/nacre control siblings. We entrained the animals as described above, and starting at 4 dpf we
treated the animals with 2 mM Csn in rearing media. We then mounted the animals for imaging at 6
dpf in the afternoon. The mounted animals were maintained in the same light:dark cycle as during
entrainment, and spontaneous calcium activity was recorded in 2 min sessions at 1 Hz, repeated
every 15 min, for 20–24 hr across the night of 6 dpf. Imaging data was collected blinded to geno-
type, and posthumous PCR genotyping was performed as described above.
Image analysis for Figure 7—figure supplement 2 was performed using Matlab. After back-
ground signal was subtracted, we performed standard Principal Component and Independent Com-
ponent Analysis (PCA/ICA) (Mukamel et al., 2009) to automatically segment neurons that exhibited
spiking activity. We typically utilized the first 15 principal components (covering ~75% of the total
signal variance), as higher order components started to be noise-dominated (determined by visual
inspection of components plotted onto the raw data time series). From raw images, we found that
neuronal nuclei have nominal diameter = 5 mm, hence ICA was performed with spatial filter of that
size. Typically, 500–800 active neurons were extracted from each 2 min imaging session. Some false
positives were extracted from skin auto-fluorescence, contributing about 5% of the total segmented
neurons, which did not contribute significantly to subsequent quantitative analysis. To establish the
baseline signal F0 for each segmented neuron, the temporal signal trace for each 2 min imaging trial
was smoothed with a sliding window of 5 s, then the minimum of the resulting signal trace was set
to be F0. DF = F – F0 was then calculated for each segmented neuron, for each time step. Figure 7—
figure supplement 2C and D show DF during the day and night, averaged over all segmented neu-
rons. In Figure 7—figure supplement 2E, F and G, day activity values were calculated as the aver-
age of both day periods (before and after the night). In Figure 7—figure supplement 2E, DF/FN is
shown during the day and night, averaged over all segmented neurons, where FN = average day
activity of the same animal. In Figure 7—figure supplement 2F, we compare the non-normalized
day neural activity, in units of fluorescence counts, and found that day neural activity was not statisti-
cally different between Tg(UAS:TRPV1-TagRFP-T) and Tg(npvf:KalTA4);Tg(UAS:TRPV1-TagRFP-T)
animals. Thus, in order to compare neural activity between the two genotypes at night, we normal-
ized night activity by FN = average day activity of the same animal (Figure 7—figure supplement
2G). Image rendering was performed using ImageJ. Graphs were generated and statistical analysis
was performed using MATLAB.
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Statistical analysis
Line graphs in Figures 1–3 and 6, Figure 1—figure supplements 1–3, Figure 2—figure supple-
ments 1–2, Figure 3—figure supplement 2, Figure 5—figure supplement 2 were generated from
raw data and smoothed over 1 hr bins in 10 min intervals to show underlying behavioral trends. Line
and bar graphs show mean ± standard error of the mean (SEM). In all statistical tests, the significance
threshold was set to p<0.05, and P values were adjusted for multiple comparisons where appropri-
ate. Parametric analyses were applied because the data followed an approximately normal distribu-
tion. Unpaired two-tailed Student’s t-test was performed using Excel. One-way and Two-way
analysis of variance (ANOVA) and post hoc tests to correct for multiple comparisons were performed
using Prism. The Holm-Sidak post hoc test was used to correct for multiple comparisons and to allow
pairwise comparison of means for all samples. In Figure 2, Dunnett’s post hoc test was used to com-
pare each of a number of treatments (RFRP transgene variants) with a single control (transgenic ani-
mal where all RFRP peptides were scrambled). In Figure 7H and Figure 7—figure supplement 2F
and G, appropriateness of a t-test was confirmed by the Kolmogorov-Smirnov normality test
(p>0.8). Then, either a one- or two-sampled t-test was carried out as described. Asterisks in figures
denote statistics for pairwise or multiple comparisons as indicated.
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